| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC4 MYL6 SPG7 MYO5A MYO6 MYO7B ZGRF1 ACSS1 HSPH1 BLM DHX15 STARD9 SUPV3L1 CHD6 TOR1B ATP13A3 HSPA4 DDX39B DYNC1H1 PIF1 ACSS3 HSPA4L SAE1 NLRP3 ORC4 DDX25 MACF1 ABCC12 SLFN11 POLQ | 9.05e-09 | 614 | 293 | 30 | GO:0140657 |
| GeneOntologyMolecularFunction | volume-sensitive anion channel activity | 5.40e-06 | 9 | 293 | 4 | GO:0005225 | |
| GeneOntologyMolecularFunction | small GTPase binding | GAPVD1 RAPGEF6 MYO5A MYCBP2 NDRG1 FGD1 PEX5 DIAPH3 IPO5 MYRIP IPO4 CDC42BPB CYRIB DAAM1 MAP2K1 | 8.62e-05 | 321 | 293 | 15 | GO:0031267 |
| GeneOntologyMolecularFunction | GTPase binding | GAPVD1 RAPGEF6 MYO5A MYCBP2 SPTBN1 NDRG1 FGD1 PEX5 DIAPH3 IPO5 MYRIP IPO4 CDC42BPB CYRIB DAAM1 MAP2K1 | 9.06e-05 | 360 | 293 | 16 | GO:0051020 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCC4 SPG7 BLM DHX15 SUPV3L1 CHD6 TOR1B ATP13A3 DDX39B DYNC1H1 PIF1 NLRP3 ORC4 DDX25 MACF1 ABCC12 SLFN11 POLQ | 9.87e-05 | 441 | 293 | 18 | GO:0016887 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | STK36 ATR PDK2 RPS6KA2 DAPK1 ACVR2B STK35 AKT2 WNK2 MOK CDC42BPB ARAF TGFBR1 MTOR PRKD1 MAP2K1 RIOK2 ALPK2 | 1.14e-04 | 446 | 293 | 18 | GO:0004674 |
| GeneOntologyMolecularFunction | helicase activity | 1.18e-04 | 158 | 293 | 10 | GO:0004386 | |
| GeneOntologyMolecularFunction | peroxisome membrane targeting sequence binding | 2.15e-04 | 2 | 293 | 2 | GO:0033328 | |
| GeneOntologyMolecularFunction | rRNA (cytosine-N4-)-methyltransferase activity | 2.15e-04 | 2 | 293 | 2 | GO:0071424 | |
| GeneOntologyMolecularFunction | protein kinase activity | EPHB6 STK36 ATR PDK2 PDK4 RPS6KA2 DAPK1 ACVR2B STK35 AKT2 WNK2 MOK FLT1 CDC42BPB ARAF TGFBR1 MTOR PRKD1 MAP2K1 RIOK2 ALPK2 | 2.27e-04 | 600 | 293 | 21 | GO:0004672 |
| GeneOntologyMolecularFunction | actin binding | MYO5A MYO6 MYO7B SPTBN1 NEB SPATA31C1 ADD1 SYN1 DIAPH3 UTRN EPS8L2 NRAP MYRIP GAS7 SHROOM2 MACF1 SSH2 DAAM1 | 2.73e-04 | 479 | 293 | 18 | GO:0003779 |
| GeneOntologyMolecularFunction | protein serine kinase activity | STK36 ATR RPS6KA2 DAPK1 STK35 AKT2 WNK2 MOK CDC42BPB ARAF MTOR PRKD1 MAP2K1 RIOK2 ALPK2 | 3.28e-04 | 363 | 293 | 15 | GO:0106310 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYO5A MYO6 MYO7B DISC1 SPTBN1 HSPH1 CKAP5 NDN ADGRV1 TUBGCP2 NEB SPATA31C1 ADD1 STIM1 NDRG1 BRCA1 BRCA2 STARD9 SYN1 TOR1B DIAPH3 UTRN EPS8L2 NRAP ANK1 MYRIP GAS7 SHROOM2 MACF1 SSH2 DAAM1 | 3.86e-04 | 1099 | 293 | 31 | GO:0008092 |
| GeneOntologyMolecularFunction | ATP-dependent protein binding | 4.73e-04 | 11 | 293 | 3 | GO:0043008 | |
| GeneOntologyMolecularFunction | cadherin binding | ATXN2L GAPVD1 SPTBN1 CKAP5 ADD1 SEPTIN2 FASN CDH20 NDRG1 AHNAK PLCB3 DIAPH3 EPS8L2 MACF1 | 5.18e-04 | 339 | 293 | 14 | GO:0045296 |
| GeneOntologyMolecularFunction | actin filament binding | MYO5A MYO6 MYO7B SPTBN1 NEB ADD1 EPS8L2 NRAP GAS7 SHROOM2 MACF1 | 5.54e-04 | 227 | 293 | 11 | GO:0051015 |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | GAPVD1 RAPGEF6 MYCBP2 RAPGEF5 MCF2L2 FGD1 CCZ1B EPS8L2 CCZ1 SBF2 RASGEF1C | 6.41e-04 | 231 | 293 | 11 | GO:0005085 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | EPHB6 STK36 CTU2 RNGTT ATR PDK2 PDK4 RPS6KA2 DAPK1 ACVR2B STK35 AKT2 WNK2 MOK FLT1 POLR2B CDC42BPB ARAF POLR3C TGFBR1 FICD MTOR PRKD1 POLQ MAP2K1 RIOK2 ALPK2 | 6.83e-04 | 938 | 293 | 27 | GO:0016772 |
| GeneOntologyMolecularFunction | signal sequence binding | 8.89e-04 | 51 | 293 | 5 | GO:0005048 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCC4 SPG7 SEPTIN2 BLM DHX15 RAB33A SUPV3L1 CHD6 TOR1B ATP13A3 DDX39B DYNC1H1 PIF1 IFT22 SEPTIN4 GTPBP10 NLRP3 ORC4 DDX25 MACF1 ABCC12 SLFN11 POLQ | 1.14e-03 | 775 | 293 | 23 | GO:0017111 |
| GeneOntologyMolecularFunction | adenyl-nucleotide exchange factor activity | 1.25e-03 | 15 | 293 | 3 | GO:0000774 | |
| GeneOntologyMolecularFunction | acetate-CoA ligase activity | 1.26e-03 | 4 | 293 | 2 | GO:0003987 | |
| GeneOntologyMolecularFunction | propionate-CoA ligase activity | 1.26e-03 | 4 | 293 | 2 | GO:0050218 | |
| GeneOntologyMolecularFunction | short-chain fatty acid-CoA ligase activity | 1.26e-03 | 4 | 293 | 2 | GO:0031955 | |
| GeneOntologyMolecularFunction | IgA binding | 1.26e-03 | 4 | 293 | 2 | GO:0019862 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCC4 RNGTT SPG7 SEPTIN2 BLM DHX15 RAB33A SUPV3L1 CHD6 TOR1B ATP13A3 DDX39B DYNC1H1 PIF1 IFT22 SEPTIN4 GTPBP10 NLRP3 ORC4 DDX25 MACF1 ABCC12 SLFN11 POLQ | 1.47e-03 | 839 | 293 | 24 | GO:0016462 |
| GeneOntologyMolecularFunction | damaged DNA binding | 1.48e-03 | 84 | 293 | 6 | GO:0003684 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCC4 RNGTT SPG7 SEPTIN2 BLM DHX15 RAB33A SUPV3L1 CHD6 TOR1B ATP13A3 DDX39B DYNC1H1 PIF1 IFT22 SEPTIN4 GTPBP10 NLRP3 ORC4 DDX25 MACF1 ABCC12 SLFN11 POLQ | 1.49e-03 | 840 | 293 | 24 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCC4 RNGTT SPG7 SEPTIN2 BLM DHX15 RAB33A SUPV3L1 CHD6 TOR1B ATP13A3 DDX39B DYNC1H1 PIF1 IFT22 SEPTIN4 GTPBP10 NLRP3 ORC4 DDX25 MACF1 ABCC12 SLFN11 POLQ | 1.49e-03 | 840 | 293 | 24 | GO:0016818 |
| GeneOntologyBiologicalProcess | guanine nucleotide transmembrane transport | 1.31e-07 | 10 | 292 | 5 | GO:1903790 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide transport | 2.37e-07 | 11 | 292 | 5 | GO:0070729 | |
| GeneOntologyBiologicalProcess | guanine nucleotide transport | 2.37e-07 | 11 | 292 | 5 | GO:0001408 | |
| GeneOntologyBiologicalProcess | alkanesulfonate transmembrane transport | 2.63e-06 | 8 | 292 | 4 | GO:0042918 | |
| GeneOntologyBiologicalProcess | cyclic-GMP-AMP transmembrane import across plasma membrane | 2.63e-06 | 8 | 292 | 4 | GO:0140361 | |
| GeneOntologyBiologicalProcess | taurine transmembrane transport | 2.63e-06 | 8 | 292 | 4 | GO:0015734 | |
| GeneOntologyBiologicalProcess | dicarboxylic acid transport | MYO6 SEPTIN2 PER2 LRRC8E LRRC8C VPS54 GRM1 SLC13A2 LRRC8D LRRC8A | 8.17e-06 | 120 | 292 | 10 | GO:0006835 |
| GeneOntologyBiologicalProcess | cellular response to environmental stimulus | ATR MYO6 ACTR5 NEDD4 BLM BRCA1 BRCA2 AKT2 LRRC8E LRRC8C XPC GRM1 LRRC8D NLRP3 LIG4 MTOR TP53BP1 | 2.40e-05 | 371 | 292 | 17 | GO:0104004 |
| GeneOntologyBiologicalProcess | cellular response to abiotic stimulus | ATR MYO6 ACTR5 NEDD4 BLM BRCA1 BRCA2 AKT2 LRRC8E LRRC8C XPC GRM1 LRRC8D NLRP3 LIG4 MTOR TP53BP1 | 2.40e-05 | 371 | 292 | 17 | GO:0071214 |
| GeneOntologyBiologicalProcess | C4-dicarboxylate transport | 4.94e-05 | 29 | 292 | 5 | GO:0015740 | |
| GeneOntologyBiologicalProcess | nucleotide transmembrane transport | 6.90e-05 | 31 | 292 | 5 | GO:1901679 | |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation | MAGEA2 VPS11 CTU2 TRAF6 CAND1 CAND2 MYCBP2 USP9X KEAP1 FEM1C COPS2 FBXL5 NEDD4 CISH FBXO38 BRCA1 PER2 ANAPC1 ANAPC2 MINAR1 SEPTIN4 SAE1 RWDD3 KLHL22 CUL5 TGFBR1 MTOR HERC4 | 7.51e-05 | 893 | 292 | 28 | GO:0032446 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | MAGEA2 USP34 VPS11 CTU2 TRAF6 CAND1 CAND2 MYCBP2 USP9X KEAP1 FEM1C COPS2 FBXL5 NEDD4 CISH FBXO38 BRCA1 PER2 ANAPC1 ANAPC2 MINAR1 SEPTIN4 SAE1 RWDD3 USP16 KLHL22 CUL5 TGFBR1 MTOR HERC4 | 1.07e-04 | 1009 | 292 | 30 | GO:0070647 |
| GeneOntologyBiologicalProcess | signal transduction in response to DNA damage | ATR MYO6 BLM BRCA1 BRCA2 XPC PPP2R5C TTI1 CD74 DOT1L TP53BP1 | 1.38e-04 | 200 | 292 | 11 | GO:0042770 |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | SEPTIN2 PER2 AKT2 LRRC8E LRRC8C GRM1 SLC13A2 LRRC8D SLC16A6 LRRC8A | 1.39e-04 | 167 | 292 | 10 | GO:1903825 |
| GeneOntologyBiologicalProcess | DNA damage checkpoint signaling | 1.41e-04 | 136 | 292 | 9 | GO:0000077 | |
| GeneOntologyBiologicalProcess | epicardium morphogenesis | 2.00e-04 | 2 | 292 | 2 | GO:1905223 | |
| GeneOntologyBiologicalProcess | SCF complex assembly | 2.00e-04 | 2 | 292 | 2 | GO:0010265 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication maintenance of fidelity | 2.02e-04 | 60 | 292 | 6 | GO:0045005 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle process | ATR INHBA RPS6KA2 BLM BRCA1 BRCA2 DIAPH3 GRB14 XPC KLHL22 PPP2R5C TTI1 SLFN11 DOT1L TP53BP1 | 2.18e-04 | 362 | 292 | 15 | GO:0010948 |
| GeneOntologyBiologicalProcess | protein hexamerization | 2.21e-04 | 9 | 292 | 3 | GO:0034214 | |
| GeneOntologyBiologicalProcess | DNA integrity checkpoint signaling | 2.28e-04 | 145 | 292 | 9 | GO:0031570 | |
| GeneOntologyBiologicalProcess | aspartate transmembrane transport | 2.35e-04 | 22 | 292 | 4 | GO:0015810 | |
| GeneOntologyBiologicalProcess | protein ubiquitination | MAGEA2 VPS11 TRAF6 CAND1 CAND2 MYCBP2 USP9X KEAP1 FEM1C FBXL5 NEDD4 CISH FBXO38 BRCA1 PER2 ANAPC1 ANAPC2 MINAR1 SEPTIN4 SAE1 KLHL22 CUL5 TGFBR1 MTOR HERC4 | 2.38e-04 | 811 | 292 | 25 | GO:0016567 |
| GeneOntologyBiologicalProcess | purine-containing compound transmembrane transport | 2.41e-04 | 40 | 292 | 5 | GO:0072530 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide transport | 2.41e-04 | 40 | 292 | 5 | GO:0015868 | |
| GeneOntologyBiologicalProcess | DNA damage response | TRAF6 ATR MYO6 ACTR5 USP9X ZGRF1 SSRP1 NEDD4 BLM FANCB BRCA1 BRCA2 SLC30A9 PIF1 PNP XPC USP16 LIG4 PPP2R5C MTOR ARID2 TP63 TTI1 CD74 SLFN11 DOT1L POLQ TP53BP1 | 2.46e-04 | 959 | 292 | 28 | GO:0006974 |
| GeneOntologyBiologicalProcess | cell cycle checkpoint signaling | ATR BLM BRCA1 BRCA2 DIAPH3 XPC KLHL22 PPP2R5C TTI1 DOT1L TP53BP1 | 2.81e-04 | 217 | 292 | 11 | GO:0000075 |
| GeneOntologyBiologicalProcess | protein targeting | VPS11 MYO6 ERBIN NEDD4 TOMM40L PEX19 PEX5 AKT2 HSPA4 VPS8 AP1M2 SAE1 VPS54 MACF1 PARD3 | 3.00e-04 | 373 | 292 | 15 | GO:0006605 |
| GeneOntologyBiologicalProcess | adenine nucleotide transport | 3.04e-04 | 42 | 292 | 5 | GO:0051503 | |
| GeneOntologyBiologicalProcess | post-translational protein modification | MAGEA2 USP34 VPS11 CTU2 TRAF6 CAND1 CAND2 MYCBP2 USP9X KEAP1 FEM1C COPS2 FBXL5 NEDD4 CISH FBXO38 BRCA1 PER2 ANAPC1 ANAPC2 MINAR1 SEPTIN4 SAE1 RWDD3 USP16 KLHL22 CUL5 TGFBR1 MTOR HERC4 | 3.13e-04 | 1074 | 292 | 30 | GO:0043687 |
| GeneOntologyBiologicalProcess | intracellular transport | GPRASP1 VPS11 SPG7 MYO5A MYO6 USP9X UBAP1 NEDD4 RFTN1 BRCA1 VPS35L PEX19 PEX5 AP1M1 DIAPH3 REEP5 HSPA4 DDX39B DYNC1H1 SEC23B DOP1B IPO5 RELCH MIA3 DNAJC13 IFT22 ANK1 VPS8 MYRIP AP1M2 VPS54 IPO4 DDX25 LRP1 CD74 PRKD1 MAP2K1 RIOK2 | 3.30e-04 | 1496 | 292 | 38 | GO:0046907 |
| GeneOntologyBiologicalProcess | purine nucleotide transport | 3.80e-04 | 44 | 292 | 5 | GO:0015865 | |
| GeneOntologyCellularComponent | cell cortex | TRAF6 MYO6 SPTBN1 NEDD4 SEPTIN2 STIM1 AKT2 NR3C2 DYNC1H1 ANK1 SEPTIN4 MYRIP SHROOM2 MACF1 PRKD1 PARD3 MAP2K1 | 2.31e-05 | 371 | 295 | 17 | GO:0005938 |
| GeneOntologyCellularComponent | actin cytoskeleton | CATIP VPS11 MYL6 MYO5A MYO6 MYO7B SPTBN1 DAPK1 KEAP1 NEB ADD1 SEPTIN2 AHNAK DIAPH3 FLT1 MYRIP GAS7 SHROOM2 CDC42BPB MACF1 DAAM1 | 7.60e-05 | 576 | 295 | 21 | GO:0015629 |
| GeneOntologyCellularComponent | endosome | VPS11 GAPVD1 TRAF6 MYO5A MYO6 UBAP1 RFTN1 RAB33A NDRG1 CLCN4 IFITM3 VPS35L AP1M1 AKT2 ATP13A3 DIAPH3 DOP1B CCZ1B RELCH FLT1 DNAJC13 VPS8 GRB14 ADAM30 WDFY4 PDIA3 TGFBR1 CCZ1 SBF2 LRP1 TJAP1 CD74 MAP2K1 | 1.17e-04 | 1167 | 295 | 33 | GO:0005768 |
| GeneOntologyCellularComponent | DNA repair complex | 2.78e-04 | 23 | 295 | 4 | GO:1990391 | |
| GeneOntologyCellularComponent | unconventional myosin complex | 4.22e-04 | 11 | 295 | 3 | GO:0016461 | |
| GeneOntologyCellularComponent | insulin-responsive compartment | 4.22e-04 | 11 | 295 | 3 | GO:0032593 | |
| HumanPheno | Displacement of the urethral meatus | ATR USP9X SPTBN1 NEB FANCB FREM2 BRCA1 BRCA2 VPS35L PEX19 FGD1 PEX5 FAT4 CDC42BPB ORC4 LIG4 C2CD3 MTOR ARID2 TP63 MAP2K1 | 1.22e-05 | 397 | 97 | 21 | HP:0100627 |
| HumanPheno | Abnormal male urethral meatus morphology | ATR USP9X SPTBN1 NEB FANCB FREM2 BRCA1 BRCA2 VPS35L PEX19 FGD1 PEX5 FAT4 CDC42BPB ORC4 LIG4 C2CD3 MTOR ARID2 TP63 MAP2K1 | 1.32e-05 | 399 | 97 | 21 | HP:0032076 |
| HumanPheno | Hypospadias | ATR USP9X SPTBN1 NEB FANCB FREM2 BRCA1 BRCA2 VPS35L PEX19 FGD1 PEX5 FAT4 CDC42BPB ORC4 LIG4 MTOR ARID2 TP63 MAP2K1 | 1.97e-05 | 377 | 97 | 20 | HP:0000047 |
| HumanPheno | Abnormality of the urethra | ATR USP9X SPTBN1 NEB FANCB FREM2 BRCA1 BRCA2 VPS35L PEX19 FGD1 PEX5 TMEM231 FAT4 CDC42BPB ORC4 LIG4 C2CD3 MTOR ARID2 TP63 MAP2K1 | 4.25e-05 | 465 | 97 | 22 | HP:0000795 |
| HumanPheno | Upslanted palpebral fissure | CTU2 HIVEP2 USP9X SPTBN1 QRICH1 TUBGCP2 FANCB BRCA1 BRCA2 PEX19 PEX5 DLG3 SLC30A9 ANK1 CDC42BPB LIG4 C2CD3 MRPS2 | 4.31e-05 | 333 | 97 | 18 | HP:0000582 |
| HumanPheno | Abnormal eyelid morphology | CTU2 HIVEP2 ATR MYO5A USP9X SPTBN1 NDN QRICH1 TUBGCP2 BLM FANCB FREM2 CLCN4 BRCA1 BRCA2 ANAPC1 VPS35L PEX19 FGD1 PEX5 DLG3 ECEL1 CHD6 UROD TMEM231 SLC30A9 GPRASP2 DYNC1H1 NOVA2 FAT4 COL9A1 ANK1 XPC CDC42BPB TGFBR1 LIG4 C2CD3 MTOR MRPS2 ARID2 TP63 LRP1 LRRC8A MACF1 MAP2K1 | 5.33e-05 | 1408 | 97 | 45 | HP:0000492 |
| HumanPheno | Abnormal iris pigmentation | MYO5A ACP5 SPTBN1 NDN ADGRV1 BLM FANCB BRCA1 BRCA2 ANAPC1 PEX19 PEX5 UROD SEC23B XPC MTOR TP63 TTI1 | 9.99e-05 | 355 | 97 | 18 | HP:0008034 |
| HumanPheno | Iris hypopigmentation | MYO5A ACP5 SPTBN1 NDN ADGRV1 BLM FANCB BRCA1 BRCA2 ANAPC1 UROD SEC23B XPC MTOR TP63 TTI1 | 1.32e-04 | 298 | 97 | 16 | HP:0007730 |
| HumanPheno | Slanting of the palpebral fissure | CTU2 HIVEP2 ATR USP9X SPTBN1 QRICH1 TUBGCP2 FANCB CLCN4 BRCA1 BRCA2 VPS35L PEX19 FGD1 PEX5 DLG3 SLC30A9 DYNC1H1 NOVA2 ANK1 CDC42BPB TGFBR1 LIG4 C2CD3 MTOR MRPS2 ARID2 MAP2K1 | 1.75e-04 | 739 | 97 | 28 | HP:0200006 |
| HumanPheno | Hypopigmentation of hair | MYO5A ACP5 SPTBN1 NDN BLM FANCB BRCA1 BRCA2 ANAPC1 UROD SEC23B XPC MTOR TP63 TTI1 | 1.92e-04 | 276 | 97 | 15 | HP:0005599 |
| HumanPheno | Ocular albinism | MYO5A ACP5 SPTBN1 NDN BLM FANCB BRCA1 BRCA2 ANAPC1 UROD SEC23B XPC MTOR TP63 TTI1 | 1.92e-04 | 276 | 97 | 15 | HP:0001107 |
| HumanPheno | Generalized hypopigmentation | MYO5A ACP5 SPTBN1 NDN BLM FANCB BRCA1 BRCA2 ANAPC1 UROD SEC23B XPC MTOR TP63 TTI1 | 1.92e-04 | 276 | 97 | 15 | HP:0007513 |
| HumanPheno | Albinism | MYO5A ACP5 SPTBN1 NDN BLM FANCB BRCA1 BRCA2 ANAPC1 UROD SEC23B XPC MTOR TP63 TTI1 | 1.92e-04 | 276 | 97 | 15 | HP:0001022 |
| HumanPheno | Hypopigmentation of the skin | MYO5A ACP5 SPTBN1 NDN BLM FANCB BRCA1 BRCA2 ANAPC1 UROD SEC23B XPC MTOR TP63 TTI1 | 1.92e-04 | 276 | 97 | 15 | HP:0001010 |
| Domain | ARM-type_fold | USP34 GPRASP1 STK36 VPS11 CAND1 CAND2 ATR USP9X CKAP5 DIAPH3 UNC79 GPRASP2 IPO5 RELCH DNAJC13 IPO4 WDFY4 PPP2R5C MROH8 MTOR ARID2 MROH2B INTS4 TTI1 DAAM1 | 1.72e-10 | 339 | 294 | 25 | IPR016024 |
| Domain | ARM-like | GPRASP1 STK36 CAND1 CAND2 ATR USP9X CKAP5 GPRASP2 IPO5 RELCH DNAJC13 IPO4 WDFY4 PPP2R5C MTOR ARID2 MROH2B INTS4 TTI1 DAAM1 | 1.13e-08 | 270 | 294 | 20 | IPR011989 |
| Domain | - | GPRASP1 STK36 CAND1 CAND2 ATR USP9X CKAP5 IPO5 RELCH DNAJC13 IPO4 WDFY4 PPP2R5C MTOR MROH2B INTS4 TTI1 DAAM1 | 1.55e-08 | 222 | 294 | 18 | 1.25.10.10 |
| Domain | HEAT_REPEAT | 1.38e-07 | 70 | 294 | 10 | PS50077 | |
| Domain | HEAT | 2.84e-07 | 58 | 294 | 9 | IPR000357 | |
| Domain | LRRC8_Pannexin-like | 2.97e-07 | 5 | 294 | 4 | IPR021040 | |
| Domain | Pannexin_like | 2.97e-07 | 5 | 294 | 4 | PF12534 | |
| Domain | HEAT | 7.49e-07 | 48 | 294 | 8 | PF02985 | |
| Domain | P-loop_NTPase | ABCC4 SPG7 GTPBP6 MYO5A MYO6 MYO7B ZGRF1 DAPK1 SEPTIN2 BLM DHX15 RAB33A STARD9 SUPV3L1 DLG3 CHD6 TOR1B DDX39B DYNC1H1 PIF1 IFT22 SEPTIN4 HNRNPUL1 GTPBP10 NLRP3 ORC4 DDX25 ABCC12 SLFN11 POLQ | 3.10e-05 | 848 | 294 | 30 | IPR027417 |
| Domain | HEAT_type_2 | 1.22e-04 | 17 | 294 | 4 | IPR021133 | |
| Domain | DUF1712 | 2.47e-04 | 2 | 294 | 2 | PF08217 | |
| Domain | TIP120 | 2.47e-04 | 2 | 294 | 2 | PF08623 | |
| Domain | TATA-bd_TIP120 | 2.47e-04 | 2 | 294 | 2 | IPR013932 | |
| Domain | DUF1712_fun | 2.47e-04 | 2 | 294 | 2 | IPR013176 | |
| Domain | - | ABCC4 SPG7 GTPBP6 MYO7B ZGRF1 SEPTIN2 BLM DHX15 RAB33A SUPV3L1 DLG3 CHD6 TOR1B DDX39B DYNC1H1 PIF1 IFT22 SEPTIN4 HNRNPUL1 GTPBP10 ORC4 DDX25 ABCC12 SLFN11 POLQ | 3.30e-04 | 746 | 294 | 25 | 3.40.50.300 |
| Domain | Kinase-like_dom | EPHB6 STK36 ATR RPS6KA2 DAPK1 ACVR2B STK35 AKT2 WNK2 MOK FLT1 CDC42BPB ARAF TGFBR1 MTOR MACF1 PRKD1 MAP2K1 RIOK2 ALPK2 | 3.95e-04 | 542 | 294 | 20 | IPR011009 |
| Domain | Clathrin_mu | 4.27e-04 | 10 | 294 | 3 | IPR001392 | |
| Domain | CA | 4.73e-04 | 115 | 294 | 8 | SM00112 | |
| Domain | Cadherin_C | 4.93e-04 | 42 | 294 | 5 | IPR032455 | |
| Domain | Cadherin_C_2 | 4.93e-04 | 42 | 294 | 5 | PF16492 | |
| Domain | Cadherin | 5.62e-04 | 118 | 294 | 8 | IPR002126 | |
| Domain | Adap_comp_sub | 5.80e-04 | 11 | 294 | 3 | PF00928 | |
| Pathway | REACTOME_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS | 3.34e-05 | 25 | 216 | 5 | MM15172 | |
| Pathway | REACTOME_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS | 4.08e-05 | 26 | 216 | 5 | M27424 | |
| Pubmed | GPRASP1 CAND1 MYO5A MYCBP2 TBL1Y USP9X RPS6KA2 SPTBN1 CKAP5 DAPK1 KEAP1 ERBIN ADD1 NEDD4 SEPTIN2 ANAPC1 SYN1 PEX5 DLG3 UNC79 DYNC1H1 WNK2 BEGAIN MIA3 DNAJC13 IPO4 GRM1 CDC42BPB CYRIB MTOR LRP1 TJAP1 MACF1 PRKD1 SSH2 PARD3 CABIN1 TP53BP1 | 7.08e-15 | 963 | 300 | 38 | 28671696 | |
| Pubmed | EPHB6 USP34 GPRASP1 TRAF6 CAND1 HIVEP2 GTPBP6 MYO5A MYCBP2 MYO6 USP9X SPTBN1 HSPH1 MCF2L2 CKAP5 QRICH1 HMOX2 SEPTIN2 DGLUCY NDRG1 SUPV3L1 VPS35L CHD6 UROD UTRN GPRASP2 DYNC1H1 DOP1B IPO5 SEMA4D MYRIP GAS7 XPC VPS54 HNRNPUL1 SHROOM2 USP16 CDC42BPB LRP1 MACF1 CD74 CABIN1 PADI2 | 3.14e-14 | 1285 | 300 | 43 | 35914814 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ATXN2L GAPVD1 RAPGEF6 HIVEP2 MYCBP2 RPS6KA2 SPTBN1 CKAP5 MCCC1 SSRP1 ERBIN NEDD4 STIM1 NDRG1 STARD9 AHNAK AP1M1 NR3C2 UTRN SEC23B ARAP2 DOP1B HNRNPUL1 ARAF CARD8 LPIN3 NHSL1 C2CD3 MTOR MACF1 SSH2 PARD3 MAP2K1 AHNAK2 | 2.04e-13 | 861 | 300 | 34 | 36931259 |
| Pubmed | USP34 GAPVD1 CAND1 RNGTT MYL6 MYO6 LIN54 MCCC1 ERBIN ADCY9 ADD1 RYR2 BLM STIM1 BRCA1 AHNAK PEX5 DLG3 TASOR DYNC1H1 SEC23B IGSF3 ARAP2 FAT4 DNAJC13 STON1 LYSMD4 HNRNPUL1 IPO4 CDC42BPB TJAP1 PARD3 | 3.57e-13 | 777 | 300 | 32 | 35844135 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ABCC4 CAND1 HIVEP2 GTPBP6 MYO5A MYCBP2 MYO6 RPS6KA2 ADGRV1 ACVR2B ERBIN ZNF461 PCNX2 NDRG1 VPS35L SEMA6A CHD6 REEP5 UTRN WNK2 SEMA4D MIA3 DNAJC13 SOBP MYRIP ADGRL1 VPS54 SHROOM2 LRRC8D NAALADL2 CDC42BPB CUL5 ANKRD44 SBF2 RASGEF1C LRP1 TJAP1 MACF1 PRKD1 DAAM1 PARD3 METTL15 ADAT2 | 4.24e-12 | 1489 | 300 | 43 | 28611215 |
| Pubmed | USP34 GAPVD1 RAPGEF6 ERP44 MYCBP2 ZGRF1 LIN54 CKAP5 KEAP1 MCCC1 FASN BRCA2 ANAPC1 AHNAK CHD6 DIAPH3 TASOR UTRN GPRASP2 DNAJC13 ARAF LRP1 | 1.97e-11 | 418 | 300 | 22 | 34709266 | |
| Pubmed | USP34 TBRG4 CAND1 CAND2 SPTBN1 HSPH1 MCCC1 HMOX2 TUBGCP2 SSRP1 COPS2 ERBIN NDUFS1 DHX15 FASN IFITM3 AHNAK VPS35L PEX19 ATP13A3 SLC30A9 REEP5 HSPA4 DYNC1H1 IPO5 HSPA4L POLR2B VPS8 HNRNPUL1 IPO4 GTPBP10 PDIA3 CYRIB LGALS3BP CUL5 MTOR MRPS2 CD74 CABIN1 SLC25A28 AHNAK2 | 2.19e-11 | 1440 | 300 | 41 | 30833792 | |
| Pubmed | GPRASP1 ATXN2L MYL6 MYO5A MYCBP2 PDK2 USP9X SPTBN1 CKAP5 MCCC1 HMOX2 ERBIN NDUFS1 RYR2 STIM1 NDRG1 PEX19 AP1M1 DLG3 AKT2 REEP5 DDX39B WNK2 IGSF3 BEGAIN RELCH MIA3 ADGRL1 SHROOM2 CDC42BPB NHSL1 PPP2R5C FAM169A MACF1 DAAM1 TP53BP1 | 2.35e-11 | 1139 | 300 | 36 | 36417873 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | USP34 GAPVD1 CAND1 MYL6 ERP44 USP9X SPTBN1 HSPH1 UBAP1 QRICH1 SSRP1 COPS2 SEPTIN2 DHX15 FASN NDRG1 AHNAK PEX5 AP1M1 PLCB3 UROD HSPA4 DDX39B DYNC1H1 SEC23B PNP IPO5 RELCH HSPA4L POLR2B SAE1 HNRNPUL1 IPO4 PDIA3 CUL5 PPP2R5C MTOR TTI1 MACF1 HERC4 AHNAK2 | 3.01e-11 | 1455 | 300 | 41 | 22863883 |
| Pubmed | ATXN2L CAND1 MYL6 MYO5A MYO6 USP9X SPTBN1 HSPH1 CKAP5 DAPK1 ERBIN NDUFS1 ADD1 SEPTIN2 DHX15 FASN PTPRZ1 SYN1 DLG3 REEP5 UTRN HSPA4 DDX39B DYNC1H1 WNK2 IPO5 DNAJC13 SEPTIN4 HSPA4L ADGRL1 GRM1 SHROOM2 CDC42BPB PDIA3 CYRIB CUL5 NHSL1 MACF1 SSH2 MAP2K1 | 6.85e-11 | 1431 | 300 | 40 | 37142655 | |
| Pubmed | UTP6 USP34 ATXN2L GAPVD1 MYO5A MYCBP2 USP9X SPTBN1 CKAP5 NDUFS1 BLM DHX15 FASN ANAPC1 AHNAK UTRN HSPA4 DYNC1H1 SEC23B PNP IPO5 HNRNPUL1 IPO4 MTOR MACF1 TP53BP1 | 1.34e-10 | 653 | 300 | 26 | 22586326 | |
| Pubmed | GPRASP1 ABCC4 RNGTT RAPGEF5 ACP5 SPTBN1 PCDHB5 CKAP5 UBAP1 DAPK1 HMOX2 ACVR2B NEB ERBIN BLM FANCB CLCN4 AHNAK VPS35L TOR1B ATP13A3 SEC23B DOP1B CCZ1B GAS7 LRRC8D APIP ORC4 MROH8 MTOR PUS10 UGT2A3 BPIFB2 SLFN11 DAAM1 POLQ TP53BP1 | 2.00e-10 | 1293 | 300 | 37 | 15342556 | |
| Pubmed | CAND2 MYO5A MYCBP2 MYO6 SPTBN1 HSPH1 MRPL10 HMOX2 SSRP1 ERBIN NDUFS1 ADCY9 ADD1 BLM STIM1 PEX19 AKT2 SEMA6A DIAPH3 TMEM231 SLC30A9 HSPA4 PNP MIA3 DNAJC13 HSPA4L POLR2B HNRNPUL1 IPO4 USP16 CDC42BPB PDIA3 LGALS3BP PTCD1 MRPS2 MACF1 DAAM1 PARD3 MAP2K1 TP53BP1 | 2.13e-10 | 1487 | 300 | 40 | 33957083 | |
| Pubmed | USP34 GAPVD1 RAPGEF6 CAND2 SPG7 ERP44 RAPGEF5 SPTBN1 HSPH1 MRPL10 COPS2 ERBIN VPS35L TASOR UTRN CCZ1B MIA3 POLR2B AKNAD1 SHROOM2 WDFY4 TGFBR1 ORC4 PPP2R5C CELF1 CCZ1 PTCD1 SBF2 MACF1 DOT1L PARD3 HERC4 TP53BP1 | 4.41e-10 | 1084 | 300 | 33 | 11544199 | |
| Pubmed | MYCBP2 MYO6 SPTBN1 QRICH1 KEAP1 ERBIN RYR2 NEDD4 CISH ANAPC2 PEX19 CHD6 DIAPH3 UTRN DYNC1H1 RNPC3 VPS8 XPC HNRNPUL1 CUL5 UBXN11 LRP1 MACF1 DAAM1 | 4.79e-10 | 591 | 300 | 24 | 15231748 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | UTP6 CAND1 MYO5A MYCBP2 MYO6 SPTBN1 HSPH1 CKAP5 MCCC1 SSRP1 ERBIN NDUFS1 BLM DHX15 FASN SUPV3L1 AHNAK AP1M1 PRR14L UTRN HSPA4 DDX39B DYNC1H1 PNP DNAJC13 POLR2B SAE1 XPC HNRNPUL1 IPO4 USP16 PDIA3 MACF1 PARD3 RIOK2 TP53BP1 AHNAK2 | 6.93e-10 | 1353 | 300 | 37 | 29467282 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ATXN2L GAPVD1 RAPGEF6 CAND1 MYL6 MYO6 HSPH1 CKAP5 KEAP1 MCCC1 ERBIN ADD1 SEPTIN2 FASN NDRG1 AHNAK PRR14L TASOR UTRN HSPA4 HNRNPUL1 USP16 PDIA3 ARID2 FAM169A MACF1 SLFN11 HERC4 TP53BP1 AHNAK2 | 8.36e-10 | 934 | 300 | 30 | 33916271 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ATXN2L GAPVD1 MYO6 SPTBN1 CKAP5 KEAP1 ERBIN ADCY9 ADD1 SEPTIN2 STIM1 FASN NDRG1 AHNAK PLCB3 DIAPH3 UTRN DDX39B EPS8L2 NHSL1 MACF1 DAAM1 PARD3 | 1.07e-09 | 565 | 300 | 23 | 25468996 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ATXN2L MYO5A MYCBP2 MYO6 HSPH1 CKAP5 KEAP1 MCCC1 ADD1 SEPTIN2 DHX15 STIM1 BRCA1 ANAPC1 AHNAK DIAPH3 DDX39B DNAJC13 C16orf96 XPC USP16 CDC42BPB POLR3C CELF1 MACF1 AHNAK2 | 1.20e-09 | 724 | 300 | 26 | 36232890 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | ATXN2L CAND1 CAND2 MYL6 MYO5A MYCBP2 MYO6 USP9X SPTBN1 HSPH1 CKAP5 SSRP1 COPS2 ADD1 SEPTIN2 DHX15 FASN NDRG1 AHNAK PEX19 HSPA4 DDX39B DYNC1H1 PNP IPO5 HSPA4L POLR2B SAE1 HNRNPUL1 IPO4 PDIA3 MACF1 SLFN11 | 1.88e-09 | 1149 | 300 | 33 | 35446349 |
| Pubmed | GAPVD1 CAND1 USP9X SPTBN1 HSPH1 CKAP5 TUBGCP2 SSRP1 NDUFS1 ADD1 SEPTIN2 DHX15 FASN AP1M1 HSPA4 DDX39B DYNC1H1 IPO5 DNAJC13 HSPA4L POLR2B HNRNPUL1 IPO4 MTOR | 2.17e-09 | 638 | 300 | 24 | 33239621 | |
| Pubmed | GAPVD1 CAND1 MYO6 HSPH1 CKAP5 KEAP1 HMOX2 ERBIN ADD1 DHX15 FASN NDRG1 STARD9 AHNAK DIAPH3 UTRN GPRASP2 SEC23B IPO5 IPO4 | 2.97e-09 | 449 | 300 | 20 | 31732153 | |
| Pubmed | LRRC8 Proteins Form Volume-Regulated Anion Channels that Sense Ionic Strength. | 5.43e-09 | 4 | 300 | 4 | 26824658 | |
| Pubmed | LRRC8A:C/E Heteromeric Channels Are Ubiquitous Transporters of cGAMP. | 5.43e-09 | 4 | 300 | 4 | 33171122 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | CAND1 ATR SPTBN1 CKAP5 TUBGCP2 BLM FASN ANAPC1 SUPV3L1 AHNAK ANAPC2 DIAPH3 DDX39B DYNC1H1 SEC23B IPO5 CCZ1B EPS8L2 DNAJC13 ORC4 CCZ1 MACF1 | 9.49e-09 | 582 | 300 | 22 | 20467437 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | USP34 STK36 RAPGEF6 HIVEP2 SPG7 GTPBP6 MYCBP2 RPS6KA2 ADCY9 PCNX2 FASN PER2 AHNAK AKT2 DYNC1H1 WNK2 IGSF3 LRRC8E SEMA4B CRYBG2 ADGRL1 CDC42BPB LPIN3 NHSL1 C2CD3 MTOR SBF2 DOT1L CABIN1 PRRT4 AHNAK2 | 1.04e-08 | 1105 | 300 | 31 | 35748872 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | UTP6 TBRG4 CAND1 MYL6 ACSS1 LIN54 HSPH1 KEAP1 MCCC1 SSRP1 NDUFS1 ADD1 DHX15 FASN AHNAK AP1M1 CHD6 HSPA4 DDX39B DYNC1H1 SEC23B ANK1 HSPA4L POLR2B SAE1 HNRNPUL1 IPO4 USP16 ORC4 CELF1 MRPS2 MAP2K1 RIOK2 LRIF1 | 1.52e-08 | 1318 | 300 | 34 | 30463901 |
| Pubmed | ATXN2L GAPVD1 MYO6 USP9X SPTBN1 HSPH1 CKAP5 KEAP1 ERBIN ADCY9 ADD1 SEPTIN2 DHX15 STIM1 FASN NDRG1 AHNAK DIAPH3 HSPA4 DYNC1H1 IPO5 HSPA4L MACF1 PARD3 | 1.60e-08 | 708 | 300 | 24 | 39231216 | |
| Pubmed | USP34 ATXN2L CAND1 RNGTT MYL6 ERP44 MYO6 USP9X HSPH1 MRPL10 SSRP1 COPS2 NDUFS1 DHX15 FASN ANAPC1 ANAPC2 HSPA4 DDX39B GPRASP2 SEC23B IPO5 IFT22 HSPA4L POLR2B HNRNPUL1 IPO4 PDIA3 CUL5 ORC4 PTCD1 MRPS2 WDR87 RIOK2 | 2.08e-08 | 1335 | 300 | 34 | 29229926 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | MYL6 ATR MYO5A MYO6 CKAP5 FASN ANAPC1 AHNAK IPO5 DNAJC13 IPO4 CDC42BPB MTOR | 2.66e-08 | 202 | 300 | 13 | 33005030 |
| Pubmed | LRRC8 involved in B cell development belongs to a novel family of leucine-rich repeat proteins. | 2.70e-08 | 5 | 300 | 4 | 15094057 | |
| Pubmed | 2.70e-08 | 5 | 300 | 4 | 24790029 | ||
| Pubmed | Renal Deletion of LRRC8/VRAC Channels Induces Proximal Tubulopathy. | 2.70e-08 | 5 | 300 | 4 | 35777784 | |
| Pubmed | USP34 ATXN2L GAPVD1 ERP44 MYCBP2 UBAP1 HMOX2 TUBGCP2 ERBIN NDUFS1 ADCY9 ADD1 SEPTIN2 ANAPC1 PEX19 PEX5 AKT2 PRR14L CHD6 REEP5 TASOR CCZ1B MIA3 POLR2B | 3.08e-08 | 733 | 300 | 24 | 34672954 | |
| Pubmed | CTU2 CAND1 MYL6 ERP44 GTPBP6 MYCBP2 HSPH1 KEAP1 NDUFS1 DHX15 FASN AHNAK ECEL1 TOR1B DIAPH3 HSPA4 DYNC1H1 SEC23B PNP IPO5 EPS8L2 MIA3 DNAJC13 POLR2B HNRNPUL1 CDC42BPB PDIA3 LGALS3BP MACF1 MAP2K1 RIOK2 HERC4 TP53BP1 | 3.49e-08 | 1297 | 300 | 33 | 33545068 | |
| Pubmed | GAPVD1 CAND1 MYO5A MYO6 USP9X HSPH1 KEAP1 SSRP1 COPS2 ERBIN BRCA1 BRCA2 AP1M1 AKT2 HSPA4 IPO5 HSPA4L XPC ARAF ARID2 LRP1 MACF1 | 4.32e-08 | 634 | 300 | 22 | 34591612 | |
| Pubmed | RNGTT MYO5A MYCBP2 USP9X SPTBN1 ERBIN ADCY9 BLM STIM1 FBXO38 RFTN1 PTPRZ1 AHNAK PEX19 UTRN RELCH MIA3 DNAJC13 POLR2B CDC42BPB PDIA3 NHSL1 C2CD3 PPP2R5C SBF2 INTS4 TTI1 SLFN11 SSH2 | 4.36e-08 | 1049 | 300 | 29 | 27880917 | |
| Pubmed | USP34 GAPVD1 TBRG4 CAND1 CAND2 KEAP1 ADGRV1 FEM1C ADCY9 SEPTIN2 MRC2 ANAPC2 WNK2 IGSF3 RELCH PPP2R5C LRRC8A DAAM1 PADI2 HERC4 | 4.54e-08 | 529 | 300 | 20 | 14621295 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | CAND1 MYL6 MYCBP2 SPTBN1 HSPH1 DAPK1 MCCC1 SEPTIN2 DHX15 FASN AHNAK UNC79 UTRN HSPA4 DYNC1H1 PNP IPO5 MIA3 AP1M2 HNRNPUL1 IPO4 PDIA3 CYRIB MACF1 AHNAK2 | 4.59e-08 | 807 | 300 | 25 | 30575818 |
| Pubmed | A protein network map of head and neck cancer reveals PIK3CA mutant drug sensitivity. | 4.90e-08 | 84 | 300 | 9 | 34591642 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | USP34 ATXN2L RNGTT USP9X ZGRF1 LIN54 MCCC1 TUBGCP2 BLM BRCA2 ANAPC1 DIAPH3 IPO4 POLR3C GPBP1L1 ARID2 MACF1 SLFN11 DOT1L LRIF1 TP53BP1 | 5.45e-08 | 588 | 300 | 21 | 38580884 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYL6 MYO6 SPTBN1 HSPH1 NDUFS1 FASN IL1R2 AHNAK HSPA4 DYNC1H1 SEC23B HSPA4L SAE1 HNRNPUL1 IPO4 PDIA3 LGALS3BP KLHL22 MTOR TTI1 DAAM1 TP53BP1 | 6.15e-08 | 647 | 300 | 22 | 26618866 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | USP34 ABCC4 ERP44 ATR MYCBP2 HSPH1 HMOX2 NXPE3 DHX15 STIM1 IGSF10 CSGALNACT2 IFITM3 MRC2 ECEL1 TOR1B TMEM231 REEP5 IGSF3 LRRC8C SEMA4B FAT4 MIA3 HSPA4L LRRC8D PDIA3 LGALS3BP TGFBR1 LRP1 LRRC8A TTI1 | 6.79e-08 | 1201 | 300 | 31 | 35696571 |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | USP34 ATXN2L GAPVD1 TBRG4 SPTBN1 PCDHB5 CKAP5 HMOX2 BLM DHX15 STIM1 FASN ANAPC1 MRC2 AHNAK VPS35L SLC30A9 REEP5 IGSF3 NOVA2 LRRC8E IPO5 MIA3 DNAJC13 XPC PDIA3 CYRIB PPP2R5C LRP1 HERC4 TP53BP1 | 7.05e-08 | 1203 | 300 | 31 | 29180619 |
| Pubmed | STK36 ERP44 MYO6 ACSS1 HSPH1 RFTN1 MINAR1 TASOR SEMA4B RNPC3 GAS7 WDFY4 CDC42BPB PTCD1 ARID2 SBF2 FAM169A MACF1 SSH2 | 7.36e-08 | 493 | 300 | 19 | 15368895 | |
| Pubmed | TBRG4 ATR USP9X PEX19 AP1M1 DOP1B IPO5 AP1M2 IPO4 PDIA3 MTOR TTI1 | 7.48e-08 | 183 | 300 | 12 | 23956138 | |
| Pubmed | ATXN2L CAND1 SPTBN1 HSPH1 CKAP5 SEPTIN2 BLM DHX15 FASN BRCA1 AHNAK HSPA4 SEC23B IPO5 HSPA4L HNRNPUL1 LGALS3BP KLHL22 TP53BP1 | 7.60e-08 | 494 | 300 | 19 | 26831064 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | TBRG4 CAND1 MYL6 ERP44 ACTR5 USP9X SPTBN1 HSPH1 CKAP5 SSRP1 DHX15 STIM1 FASN AHNAK AP1M1 PLCB3 DIAPH3 HSPA4 DDX39B DYNC1H1 SEC23B IPO5 HSPA4L POLR2B HNRNPUL1 LRRC8D GTPBP10 PDIA3 LGALS3BP ORC4 MRPS2 MACF1 RIOK2 AHNAK2 | 8.34e-08 | 1415 | 300 | 34 | 28515276 |
| Pubmed | CAND1 RNGTT GTPBP6 MYO5A ACTR5 TBL1Y HSPH1 CKAP5 SSRP1 ERBIN NDUFS1 BLM RFTN1 BRCA1 ANAPC1 INTS15 DLG3 CHD6 TASOR UTRN POLR2B XPC IPO4 GTPBP10 CDC42BPB ARAF ORC4 PPP2R5C GPBP1L1 PTCD1 MRPS2 ARID2 MACF1 DAAM1 PARD3 | 1.02e-07 | 1497 | 300 | 35 | 31527615 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | ATXN2L CAND1 MYL6 MYO5A MYO6 SSRP1 DHX15 FASN AHNAK UTRN DDX39B DYNC1H1 TP63 AHNAK2 | 1.05e-07 | 268 | 300 | 14 | 33024031 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | CAND1 CAND2 RNGTT MYL6 ERP44 MYCBP2 MYO6 USP9X HSPH1 KEAP1 SSRP1 NDUFS1 DHX15 FASN ANAPC1 AP1M1 HSPA4 DDX39B DYNC1H1 SEC23B PNP IPO5 CCZ1B HSPA4L POLR2B SAE1 HNRNPUL1 IPO4 CYRIB LGALS3BP CCZ1 | 1.85e-07 | 1257 | 300 | 31 | 37317656 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | GPRASP1 ATXN2L CAND1 HIVEP2 MYL6 ERP44 MYCBP2 MYO6 KEAP1 HMOX2 TUBGCP2 FEM1C COPS2 NDUFS1 FBXO38 BRCA1 UTRN GPRASP2 IPO5 IPO4 USP16 KLHL22 CUL5 CELF1 LRP1 ABCC12 TP53BP1 | 2.29e-07 | 1005 | 300 | 27 | 19615732 |
| Pubmed | USP9X SPTBN1 CKAP5 FASN AHNAK PEX19 DDX39B DYNC1H1 IPO5 ANK1 SAE1 CDC42BPB MACF1 ALPK2 AHNAK2 | 2.42e-07 | 332 | 300 | 15 | 37433992 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | GAPVD1 USP9X SPTBN1 CKAP5 FBXO38 FASN ANAPC1 AHNAK DDX39B DYNC1H1 SAE1 ARID2 TTI1 TP53BP1 AHNAK2 | 2.42e-07 | 332 | 300 | 15 | 32786267 |
| Pubmed | 2.63e-07 | 17 | 300 | 5 | 18279309 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | UTP6 GAPVD1 TBRG4 CAND1 MYL6 ERP44 ATR MYO6 USP9X SPTBN1 HSPH1 CKAP5 SSRP1 NDUFS1 SEPTIN2 DHX15 FASN ANAPC1 STARD9 SUPV3L1 AP1M1 HSPA4 DDX39B DYNC1H1 IPO5 HSPA4L POLR2B HNRNPUL1 IPO4 GRM1 PDIA3 MROH8 MTOR | 3.03e-07 | 1425 | 300 | 33 | 30948266 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | TBRG4 GTPBP6 MYCBP2 MYO6 PDK2 ACSS1 MRPL10 HMOX2 SSRP1 NDUFS1 ADCY9 BLM STIM1 SUPV3L1 PEX19 PEX5 DIAPH3 SLC30A9 DDX39B SEC23B IPO5 MIA3 HSPA4L POLR2B HNRNPUL1 GTPBP10 PDIA3 ARAF LGALS3BP MRPS2 ARID2 FAM169A METTL15 AHNAK2 | 3.04e-07 | 1496 | 300 | 34 | 32877691 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ATXN2L GAPVD1 RAPGEF6 ATR MYCBP2 SPTBN1 CKAP5 SSRP1 ERBIN ADD1 BLM FBXO38 FASN NDRG1 ANAPC1 PLCB3 DNAJC13 XPC HNRNPUL1 USP16 TJAP1 PARD3 TP53BP1 | 3.34e-07 | 774 | 300 | 23 | 15302935 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | ATXN2L CAND1 USP9X LIN54 SPTBN1 HSPH1 CKAP5 KEAP1 MCCC1 SSRP1 COPS2 ERBIN SEPTIN2 DHX15 FASN MRC2 SUPV3L1 AHNAK AP1M1 REEP5 UTRN HSPA4 DNAJC13 HNRNPUL1 IPO4 PDIA3 CYRIB LGALS3BP MTOR LRP1 TP53BP1 AHNAK2 | 3.66e-07 | 1367 | 300 | 32 | 32687490 |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | ATXN2L CAND1 ERP44 USP9X SPTBN1 HSPH1 CKAP5 SEPTIN2 FASN HSPA4 DYNC1H1 SEC23B IPO5 HSPA4L TP53BP1 | 3.80e-07 | 344 | 300 | 15 | 30333137 |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | GAPVD1 CAND1 MYL6 USP9X HSPH1 MCCC1 TUBGCP2 DHX15 FASN AP1M1 HSPA4 DYNC1H1 HSPA4L AP1M2 IPO4 | 3.80e-07 | 344 | 300 | 15 | 36282215 |
| Pubmed | ATXN2L GAPVD1 RAPGEF6 MYCBP2 USP9X KEAP1 SSRP1 ERBIN ADD1 FASN ANAPC1 AHNAK DIAPH3 DYNC1H1 POLR2B ARID2 DOT1L PARD3 TP53BP1 | 3.83e-07 | 549 | 300 | 19 | 38280479 | |
| Pubmed | PDE6A GTPBP6 MYO5A LIN54 SPTBN1 HSPH1 HMOX2 SSRP1 NEB ERBIN NDUFS1 RYR2 RFTN1 FASN CLCN4 BRCA1 STARD9 AHNAK DLG3 CHD6 DIAPH3 TASOR DDX39B HSPA4L MYRIP XPC PDIA3 LIG4 C2CD3 FAM169A MACF1 POLQ RBBP9 | 3.94e-07 | 1442 | 300 | 33 | 35575683 | |
| Pubmed | MYO6 SPTBN1 HSPH1 CKAP5 COPS2 NDUFS1 FBXL5 DHX15 FASN MRC2 ECEL1 TOR1B TMEM231 IGSF3 IPO5 POLR2B ARAF LGALS3BP LRP1 TTI1 | 4.75e-07 | 613 | 300 | 20 | 22268729 | |
| Pubmed | TBRG4 MYO6 HSPH1 CKAP5 MCCC1 TUBGCP2 COPS2 NDUFS1 ADD1 ANAPC1 ANAPC2 AP1M1 DYNC1H1 IPO5 POLR2B IPO4 PPP2R5C INTS4 SLFN11 | 5.15e-07 | 560 | 300 | 19 | 35241646 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | GAPVD1 TRAF6 CAND2 RNGTT MYL6 MYCBP2 SSRP1 COPS2 NDUFS1 BLM STIM1 FANCB AHNAK TMEM231 RSPH9 DYNC1H1 RELCH DNAJC13 IFT22 HNRNPUL1 IPO4 PDIA3 ARAF LPIN3 PPP2R5C GPBP1L1 MTOR TTI1 PRKD1 PARD3 TP53BP1 | 5.36e-07 | 1321 | 300 | 31 | 27173435 |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | MYL6 MYO5A MYO6 RPS6KA2 SPTBN1 HSPH1 MCCC1 NDUFS1 ADD1 DHX15 FASN BRCA2 SYN1 DYNC1H1 IPO5 ANK1 SEPTIN4 MTOR PARD3 MAP2K1 | 5.81e-07 | 621 | 300 | 20 | 22794259 |
| Pubmed | Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | MAGEA2 CAND1 MYL6 MYO5A MYCBP2 MYO6 DHX15 DYNC1H1 SEC23B AP1M2 IPO4 PRKD1 DOT1L | 5.90e-07 | 264 | 300 | 13 | 32814769 |
| Pubmed | 53BP1 loss rescues embryonic lethality but not genomic instability of BRCA1 total knockout mice. | 6.35e-07 | 3 | 300 | 3 | 32139898 | |
| Pubmed | 6.35e-07 | 3 | 300 | 3 | 24672057 | ||
| Pubmed | 6.44e-07 | 20 | 300 | 5 | 11322959 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | USP34 VPS11 ATR USP9X HSPH1 HMOX2 ADCY9 SEPTIN2 BLM DGLUCY NDRG1 MRC2 TOR1B ATP13A3 REEP5 DDX39B SEMA4B LRRC8D PDIA3 CYRIB TGFBR1 ORC4 SLC16A6 LRRC8A INTS4 TTI1 MACF1 | 6.56e-07 | 1061 | 300 | 27 | 33845483 |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | USP34 CAND1 USP9X HSPH1 KEAP1 SSRP1 NDUFS1 SEPTIN2 DHX15 FASN ANAPC1 HSPA4 DDX39B DYNC1H1 SEC23B HSPA4L POLR2B IPO4 CUL5 | 6.89e-07 | 571 | 300 | 19 | 37167062 |
| Pubmed | A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility. | 7.27e-07 | 37 | 300 | 6 | 19116388 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | UTP6 GAPVD1 TBRG4 CAND1 CAND2 ERP44 MYO6 USP9X HSPH1 QRICH1 HMOX2 TUBGCP2 STIM1 FASN ANAPC2 SLC30A9 HSPA4 GPRASP2 DYNC1H1 MIA3 OBP2A HSPA4L POLR2B IPO4 MTOR | 8.17e-07 | 942 | 300 | 25 | 31073040 |
| Pubmed | MYL6 MYO6 NEDD4 SEPTIN2 FASN AHNAK UTRN HSPA4 DYNC1H1 CDC42BPB MACF1 | 9.56e-07 | 191 | 300 | 11 | 33762435 | |
| Pubmed | 1.09e-06 | 10 | 300 | 4 | 22969705 | ||
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | USP34 ATXN2L CAND1 USP9X SPTBN1 FASN AHNAK WNK2 IPO5 POLR2B MRPS2 TP53BP1 | 1.10e-06 | 235 | 300 | 12 | 30258100 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | CAND1 MYO5A USP9X SPTBN1 NEDD4 AHNAK DLG3 DYNC1H1 BEGAIN GRM1 MTOR MACF1 MAP2K1 | 1.19e-06 | 281 | 300 | 13 | 28706196 |
| Pubmed | MYL6 USP9X HSPH1 MCCC1 ADGRV1 TUBGCP2 ERBIN STARD9 DLG3 BEGAIN ADGRL1 CDC42BPB ARAF MACF1 PARD3 MAP2K1 | 1.27e-06 | 430 | 300 | 16 | 32581705 | |
| Pubmed | ATXN2L ABCC4 CAND1 MYL6 MYO5A MYCBP2 MYO6 USP9X CKAP5 HMOX2 TUBGCP2 FASN CSGALNACT2 AHNAK AP1M1 ATP13A3 DYNC1H1 IPO5 LRRC8C MIA3 DNAJC13 IPO4 LRRC8D CELF1 MTOR LRRC8A CD74 DAAM1 | 1.30e-06 | 1168 | 300 | 28 | 19946888 | |
| Pubmed | ATXN2L CAND1 RNGTT MYL6 MYCBP2 LIN54 HSPH1 CKAP5 QRICH1 TUBGCP2 SSRP1 SEPTIN2 DHX15 FASN BRCA1 HSPA4 DYNC1H1 PNP SAE1 HNRNPUL1 PDIA3 CELF1 CCZ1 ARID2 SLFN11 LRIF1 TP53BP1 | 1.37e-06 | 1103 | 300 | 27 | 34189442 | |
| Pubmed | CAND1 ERP44 ATR MYCBP2 HMOX2 NDUFS1 BLM STIM1 REEP5 HSPA4 MIA3 HSPA4L XPC | 1.39e-06 | 285 | 300 | 13 | 32838362 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | UTP6 GAPVD1 RAPGEF6 USP9X UBAP1 KEAP1 SSRP1 ERBIN ADD1 SEPTIN2 PEX19 PEX5 AP1M1 DIAPH3 SEC23B BEGAIN EPS8L2 POLR2B ARAF LPIN3 GPBP1L1 MTOR SBF2 TJAP1 SSH2 RIOK2 | 1.43e-06 | 1038 | 300 | 26 | 26673895 |
| Pubmed | A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy. | 1.50e-06 | 65 | 300 | 7 | 27453043 | |
| Pubmed | ATXN2L GAPVD1 CAND1 MYL6 MYO6 SPTBN1 HSPH1 SSRP1 ERBIN NDUFS1 ADD1 DHX15 FASN NDRG1 HSPA4 DDX39B DYNC1H1 IPO5 HSPA4L POLR2B SAE1 HNRNPUL1 PDIA3 ARAF MRPS2 WDR87 DOT1L PARD3 MAP2K1 | 1.52e-06 | 1247 | 300 | 29 | 27684187 | |
| Pubmed | RAPGEF6 CAND1 CAND2 MYL6 HSPH1 MCCC1 COPS2 HSPA4 HSPA4L POLR2B IPO4 CUL5 | 1.63e-06 | 244 | 300 | 12 | 30349055 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | ATXN2L GAPVD1 RNGTT MYCBP2 USP9X SSRP1 BLM ANAPC1 HSPA4 DDX39B MIA3 HSPA4L POLR2B HNRNPUL1 ARID2 TP53BP1 | 1.71e-06 | 440 | 300 | 16 | 34244565 |
| Pubmed | CAND1 PDE6A MYL6 MYO5A MYO6 SPTBN1 NDUFS1 ADD1 NDRG1 SYN1 HSPA4 DDX39B DYNC1H1 HSPA4L SAE1 HNRNPUL1 PDIA3 FAM169A | 1.81e-06 | 552 | 300 | 18 | 36293380 | |
| Pubmed | EPHB6 USP9X RPS6KA2 KEAP1 NEDD4 AKT2 ECEL1 PLCB3 MMP10 SEC23B WNK2 SEMA4D SEMA4B POLR2B ADAM30 CDC42BPB PDIA3 PPP2R5C LRP1 SSH2 MAP2K1 | 1.83e-06 | 730 | 300 | 21 | 34857952 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | ACTR5 SPTBN1 HSPH1 SSRP1 BLM ANAPC1 AHNAK UTRN IPO5 HSPA4L XPC HNRNPUL1 CELF1 ARID2 TP53BP1 | 2.06e-06 | 394 | 300 | 15 | 27248496 |
| Pubmed | CAND1 MYO5A RPS6KA2 SPTBN1 ERBIN SEPTIN2 SYN1 DLG3 DYNC1H1 BEGAIN LRP1 MACF1 | 2.18e-06 | 251 | 300 | 12 | 27507650 | |
| Pubmed | GAPVD1 RAPGEF6 KEAP1 ERBIN ADD1 PEX5 UTRN MIA3 STON1 NHSL1 MACF1 | 2.30e-06 | 209 | 300 | 11 | 36779422 | |
| Pubmed | 2.53e-06 | 4 | 300 | 3 | 15539948 | ||
| Pubmed | 2.53e-06 | 4 | 300 | 3 | 15726604 | ||
| Pubmed | 2.53e-06 | 4 | 300 | 3 | 22789542 | ||
| Pubmed | 2.53e-06 | 4 | 300 | 3 | 28193731 | ||
| Pubmed | ATR inhibition broadly sensitizes ovarian cancer cells to chemotherapy independent of BRCA status. | 2.53e-06 | 4 | 300 | 3 | 23548269 | |
| Pubmed | 2.53e-06 | 4 | 300 | 3 | 20513533 | ||
| Pubmed | Quantitative nuclear proteomics identifies mTOR regulation of DNA damage response. | 2.53e-06 | 4 | 300 | 3 | 19955088 | |
| Interaction | HSP90AA1 interactions | EPHB6 STK36 TRAF6 CAND1 ATR PDK2 PDK4 RPS6KA2 SPTBN1 HSPH1 DAPK1 NDN KEAP1 ACVR2B STK35 ERBIN BLM FBXO38 FASN NDRG1 BRCA1 PER2 BRCA2 ANAPC2 AKT2 NR3C2 PRR14L HSPA4 DYNC1H1 ARAF NLRP3 LGALS3BP KLHL22 CUL5 TGFBR1 MTOR WDR87 LRP1 LRRC8A PRKD1 SLFN11 DOT1L MAP2K1 HERC4 | 8.30e-08 | 1263 | 296 | 44 | int:HSP90AA1 |
| Interaction | ENO1 interactions | TRAF6 RAPGEF6 CAND1 ATR MYO6 UBAP1 NDN QRICH1 SSRP1 NEB COPS2 NEDD4 DHX15 BRCA1 PER2 TOMM40L AHNAK DIAPH3 DDX39B DYNC1H1 PNP IPO5 FAT4 IPO4 PDIA3 ARAF CUL5 LIG4 C2CD3 TP53BP1 | 1.74e-07 | 701 | 296 | 30 | int:ENO1 |
| Interaction | RHOF interactions | CAND1 GTPBP6 ATR MYO5A MYO6 USP9X SPTBN1 TUBGCP2 SSRP1 ERBIN ADCY9 ADD1 STIM1 NDRG1 PLCB3 ATP13A3 DIAPH3 UTRN IGSF3 FAT4 SAE1 ADGRL1 CDC42BPB MTOR FAM169A LRRC8A MACF1 PARD3 MAP2K1 | 2.45e-07 | 673 | 296 | 29 | int:RHOF |
| Interaction | HSP90AB1 interactions | EPHB6 TRAF6 CAND1 MYL6 MYCBP2 PDK2 PDK4 HSPH1 CKAP5 NDN KEAP1 TUBGCP2 NEB COPS2 STK35 NEDD4 DHX15 FASN BRCA1 BRCA2 AHNAK NR3C2 HSPA4 DDX39B SEC23B HNRNPUL1 WDFY4 PDIA3 ARAF LGALS3BP CUL5 MTOR TP63 LRRC8A MAP2K1 | 7.16e-07 | 960 | 296 | 35 | int:HSP90AB1 |
| Interaction | EGLN3 interactions | USP34 GAPVD1 CAND1 ERP44 MYCBP2 MYO6 USP9X HSPH1 CKAP5 QRICH1 KEAP1 HMOX2 TUBGCP2 COPS2 ERBIN NDUFS1 BLM STIM1 FASN BRCA1 BRCA2 ANAPC1 NR3C2 PRR14L DIAPH3 SLC30A9 UTRN HSPA4 GPRASP2 DYNC1H1 SEC23B IPO5 IFT22 POLR2B SAE1 IPO4 ARAF NHSL1 GPBP1L1 TJAP1 PARD3 RIOK2 | 1.15e-06 | 1296 | 296 | 42 | int:EGLN3 |
| Interaction | HNRNPDL interactions | TBRG4 CAND1 NDN SSRP1 DHX15 FASN BRCA1 SUPV3L1 AHNAK HNRNPUL1 PDIA3 CUL5 CELF1 LRP1 PRKD1 SLFN11 MAP2K1 METTL15 TP53BP1 | 2.06e-06 | 364 | 296 | 19 | int:HNRNPDL |
| Interaction | RHOQ interactions | MYO5A SPTBN1 ERBIN ADCY9 ADD1 NDRG1 DLG3 AKT2 SEMA6A ATP13A3 DIAPH3 UTRN IGSF3 LRRC8C RELCH CDC42BPB TGFBR1 MTOR LRRC8A DAAM1 PARD3 | 2.65e-06 | 442 | 296 | 21 | int:RHOQ |
| Interaction | C2CD4B interactions | 3.30e-06 | 44 | 296 | 7 | int:C2CD4B | |
| Interaction | CDH1 interactions | ATXN2L GAPVD1 MYO6 USP9X SPTBN1 CKAP5 KEAP1 ERBIN ADCY9 ADD1 SEPTIN2 STIM1 FASN NDRG1 BRCA1 AHNAK AP1M1 PLCB3 DIAPH3 UTRN DDX39B EPS8L2 C16orf96 LGALS3BP NHSL1 MACF1 DAAM1 PARD3 MAP2K1 | 3.49e-06 | 768 | 296 | 29 | int:CDH1 |
| Interaction | RHOD interactions | MYO5A MYO6 USP9X SPTBN1 SSRP1 ERBIN NDUFS1 ADCY9 ADD1 STIM1 ATP13A3 DIAPH3 UTRN IGSF3 ADGRL1 LRRC8D CDC42BPB TGFBR1 MTOR LRRC8A MACF1 DAAM1 PARD3 MAP2K1 | 4.39e-06 | 572 | 296 | 24 | int:RHOD |
| Interaction | YAP1 interactions | ATXN2L GAPVD1 TRAF6 RAPGEF6 CAND1 MYL6 ERP44 MYO6 USP9X SPTBN1 HSPH1 CKAP5 SSRP1 ERBIN ADD1 NEDD4 SEPTIN2 DHX15 FASN NDRG1 ANAPC1 AHNAK HSPA4 DDX39B DYNC1H1 IPO5 HSPA4L POLR2B HNRNPUL1 PDIA3 ARID2 TP63 PRKD1 DOT1L PARD3 MAP2K1 | 5.28e-06 | 1095 | 296 | 36 | int:YAP1 |
| Interaction | YWHAB interactions | ATXN2L GAPVD1 RAPGEF6 MYCBP2 SPTBN1 HSPH1 DAPK1 NEB ERBIN NEDD4 DHX15 STIM1 STARD9 REEP5 HSPA4 GPRASP2 DYNC1H1 SEC23B ARAP2 IPO5 HNRNPUL1 ARAF LPIN3 NHSL1 PPP2R5C GPBP1L1 MTOR MACF1 CD74 SSH2 DOT1L PARD3 MAP2K1 AHNAK2 | 6.50e-06 | 1014 | 296 | 34 | int:YWHAB |
| Interaction | BRCA1 interactions | ATXN2L GAPVD1 CAND1 RNGTT ATR USP9X SPTBN1 HSPH1 CKAP5 KEAP1 SSRP1 SEPTIN2 BLM DHX15 FBXO38 FANCB FASN BRCA1 BRCA2 AHNAK PEX5 AP1M1 HSPA4 DDX39B DYNC1H1 SEC23B IPO5 HSPA4L HNRNPUL1 LGALS3BP KLHL22 ANKRD44 PPP2R5C MTOR TP63 SLFN11 CABIN1 ADAT2 TP53BP1 | 6.97e-06 | 1249 | 296 | 39 | int:BRCA1 |
| Interaction | LRRC8B interactions | 7.57e-06 | 33 | 296 | 6 | int:LRRC8B | |
| Interaction | SUMO2 interactions | GAPVD1 USP9X SPTBN1 CKAP5 SSRP1 NEDD4 BLM FBXO38 FASN BRCA1 ANAPC1 AHNAK ANAPC2 DDX39B DYNC1H1 SEC23B IPO5 SOBP SAE1 PDIA3 ARID2 TTI1 TP53BP1 AHNAK2 | 7.61e-06 | 591 | 296 | 24 | int:SUMO2 |
| Interaction | LRRC31 interactions | MYL6 ATR MYO5A MYO6 CKAP5 FASN ANAPC1 AHNAK IPO5 DNAJC13 IPO4 CDC42BPB MTOR | 1.13e-05 | 205 | 296 | 13 | int:LRRC31 |
| Interaction | FLT4 interactions | USP9X HSPH1 MRPL10 NEDD4 STIM1 DYNC1H1 SEC23B IPO5 FLT1 MIA3 HSPA4L POLR2B IPO4 PDIA3 LGALS3BP | 1.30e-05 | 272 | 296 | 15 | int:FLT4 |
| Interaction | PHF21A interactions | USP34 GAPVD1 RAPGEF6 MYCBP2 ZGRF1 CKAP5 KEAP1 MCCC1 BRCA2 ANAPC1 AHNAK CHD6 DIAPH3 UTRN GPRASP2 DNAJC13 ARAF | 1.40e-05 | 343 | 296 | 17 | int:PHF21A |
| Interaction | YWHAH interactions | ATXN2L GAPVD1 RAPGEF6 HIVEP2 MYCBP2 SPTBN1 HSPH1 CKAP5 SSRP1 ERBIN NEDD4 STIM1 NDRG1 STARD9 AHNAK NR3C2 UTRN HSPA4 SEC23B WNK2 ARAP2 DOP1B HNRNPUL1 ARAF LPIN3 NHSL1 C2CD3 GPBP1L1 MTOR MACF1 PRKD1 SSH2 PARD3 MAP2K1 AHNAK2 | 1.51e-05 | 1102 | 296 | 35 | int:YWHAH |
| Interaction | SIRT7 interactions | UTP6 USP34 ATXN2L GAPVD1 ATR MYO5A MYCBP2 USP9X SPTBN1 CKAP5 NDUFS1 BLM DHX15 FASN ANAPC1 AHNAK UTRN HSPA4 DYNC1H1 SEC23B PNP IPO5 HNRNPUL1 IPO4 MTOR MACF1 TP53BP1 | 1.56e-05 | 744 | 296 | 27 | int:SIRT7 |
| Interaction | C11orf52 interactions | SPTBN1 ERBIN ADCY9 ADD1 RFTN1 NDRG1 DLG3 AKT2 SEMA6A ATP13A3 UTRN IGSF3 ARAP2 CDC42BPB MACF1 PARD3 | 1.59e-05 | 311 | 296 | 16 | int:C11orf52 |
| Interaction | YWHAG interactions | ATXN2L GAPVD1 RAPGEF6 HIVEP2 MYCBP2 DISC1 SPTBN1 HSPH1 CKAP5 ERBIN NEDD4 DHX15 STIM1 NDRG1 STARD9 AP1M1 UTRN HSPA4 DDX39B GPRASP2 DYNC1H1 SEC23B ARAP2 HNRNPUL1 SHROOM2 ARAF LPIN3 NHSL1 C2CD3 GPBP1L1 MTOR MACF1 PRKD1 SLFN11 SSH2 PARD3 MAP2K1 AHNAK2 | 1.63e-05 | 1248 | 296 | 38 | int:YWHAG |
| Interaction | KCTD13 interactions | GPRASP1 ATXN2L CAND1 MYL6 MYO5A MYO6 USP9X SPTBN1 HSPH1 CKAP5 DAPK1 ERBIN NDUFS1 ADD1 SEPTIN2 DHX15 FASN PTPRZ1 SYN1 DLG3 REEP5 UTRN HSPA4 DDX39B DYNC1H1 WNK2 IPO5 DNAJC13 SEPTIN4 HSPA4L ADGRL1 GRM1 SHROOM2 CDC42BPB PDIA3 CYRIB CUL5 NHSL1 MACF1 SSH2 MAP2K1 | 1.65e-05 | 1394 | 296 | 41 | int:KCTD13 |
| Interaction | SMAD2 interactions | USP9X SPTBN1 ACVR2B ERBIN NEDD4 CISH BRCA1 BRCA2 ANAPC2 PEX19 AP1M1 HSPA4 DYNC1H1 RNPC3 CUL5 TGFBR1 PARD3 MAP2K1 | 1.72e-05 | 385 | 296 | 18 | int:SMAD2 |
| Interaction | POLQ interactions | 1.79e-05 | 23 | 296 | 5 | int:POLQ | |
| Interaction | NAA40 interactions | ATXN2L GAPVD1 RAPGEF6 CAND1 MYL6 MYO6 HSPH1 CKAP5 KEAP1 MCCC1 SSRP1 ERBIN ADD1 SEPTIN2 FASN NDRG1 AHNAK PRR14L TASOR UTRN HSPA4 XPC HNRNPUL1 USP16 PDIA3 ARID2 FAM169A MACF1 SLFN11 HERC4 TP53BP1 AHNAK2 | 2.01e-05 | 978 | 296 | 32 | int:NAA40 |
| Interaction | PFN1 interactions | TRAF6 RAPGEF6 CAND1 MYO5A SPTBN1 NDN NEDD4 FASN BRCA1 DIAPH3 DDX39B DOP1B DNAJC13 PDIA3 NHSL1 LIG4 TP63 MACF1 LRIF1 TP53BP1 AHNAK2 | 2.27e-05 | 509 | 296 | 21 | int:PFN1 |
| Interaction | YWHAZ interactions | ATXN2L GAPVD1 RAPGEF6 HIVEP2 ERP44 MYO5A MYCBP2 DISC1 SPTBN1 CKAP5 NEB ERBIN NEDD4 STIM1 BRCA1 PER2 STARD9 SYN1 PRR14L HSPA4 DYNC1H1 WNK2 ARAP2 HNRNPUL1 ARAF LPIN3 NHSL1 PPP2R5C GPBP1L1 MTOR MACF1 CD74 PRKD1 SLFN11 SSH2 PARD3 MAP2K1 PADI2 TP53BP1 | 2.41e-05 | 1319 | 296 | 39 | int:YWHAZ |
| Interaction | KLHL40 interactions | 2.44e-05 | 59 | 296 | 7 | int:KLHL40 | |
| Interaction | SEC23A interactions | CAND1 MYCBP2 USP9X HSPH1 NDRG1 BRCA1 IFITM3 AP1M1 MINAR1 HSPA4 SEC23B MIA3 HSPA4L USP16 | 2.65e-05 | 255 | 296 | 14 | int:SEC23A |
| Interaction | PTGES3 interactions | UTP6 PDK4 ZGRF1 RPS6KA2 NDN FBXO38 FANCB BRCA2 IFITM3 NR3C2 PRR14L TASOR REXO5 POLR2B AP1M2 CDC42BPB ARAF PPP2R5C POLQ | 2.75e-05 | 437 | 296 | 19 | int:PTGES3 |
| Interaction | HTT interactions | ATXN2L TRAF6 MYL6 MYO5A MYO6 PDK2 USP9X RPS6KA2 SPTBN1 HSPH1 MCCC1 NDUFS1 ADD1 DHX15 FASN BRCA2 SYN1 HSPA4 GPRASP2 DYNC1H1 WNK2 IPO5 ANK1 SEPTIN4 IPO4 GRM1 FICD PPP2R5C MTOR PARD3 MAP2K1 | 2.82e-05 | 949 | 296 | 31 | int:HTT |
| Interaction | VCP interactions | TRAF6 ERP44 MYCBP2 MYO6 SPTBN1 HSPH1 MRPL10 KEAP1 HMOX2 TUBGCP2 NEB NDUFS1 ADD1 BLM DHX15 STIM1 NDRG1 BRCA1 PER2 IFITM3 PEX19 DIAPH3 UROD HSPA4 DYNC1H1 PNP IPO5 RELCH POLR2B IPO4 PDIA3 CYRIB POLR3C CUL5 UBXN11 MTOR TP63 SLFN11 DOT1L MAP2K1 TP53BP1 | 3.22e-05 | 1435 | 296 | 41 | int:VCP |
| Interaction | STIP1 interactions | GAPVD1 CAND1 PDK2 USP9X SPTBN1 HSPH1 CKAP5 TUBGCP2 SSRP1 NEB NDUFS1 ADD1 SEPTIN2 DHX15 FASN BRCA1 IFITM3 AHNAK ANAPC2 AP1M1 HSPA4 DDX39B DYNC1H1 IPO5 DNAJC13 HSPA4L POLR2B HNRNPUL1 IPO4 WDFY4 MTOR SLFN11 | 3.48e-05 | 1006 | 296 | 32 | int:STIP1 |
| Interaction | PRKCZ interactions | TRAF6 CAND1 KEAP1 FASN PTPRZ1 AKT2 BEGAIN IPO5 DNAJC13 GRB14 CDC42BPB PDIA3 MTOR MRPS2 PRKD1 SLFN11 PARD3 MAP2K1 | 4.20e-05 | 412 | 296 | 18 | int:PRKCZ |
| Interaction | YWHAE interactions | ATXN2L GAPVD1 RAPGEF6 CAND1 HIVEP2 MYCBP2 DISC1 CKAP5 ERBIN NEDD4 STIM1 BRCA1 PER2 SYN1 HSPA4 DYNC1H1 SEC23B WNK2 ARAP2 NRAP SAE1 HNRNPUL1 SHROOM2 ARAF KLHL22 LPIN3 PPP2R5C GPBP1L1 MTOR MACF1 CD74 PRKD1 SLFN11 SSH2 DOT1L PARD3 MAP2K1 | 4.30e-05 | 1256 | 296 | 37 | int:YWHAE |
| Interaction | ITGB3 interactions | ATXN2L CAND1 USP9X SPTBN1 HSPH1 PTPRZ1 HSPA4 DYNC1H1 IPO5 HSPA4L TP53BP1 | 4.45e-05 | 170 | 296 | 11 | int:ITGB3 |
| Interaction | RCOR1 interactions | USP34 RAPGEF6 MYCBP2 ZGRF1 CKAP5 KEAP1 MCCC1 FASN BRCA2 ANAPC1 AHNAK CHD6 TASOR UTRN HSPA4 GPRASP2 DNAJC13 ARAF FAM169A TP53BP1 | 4.63e-05 | 494 | 296 | 20 | int:RCOR1 |
| Interaction | RHOB interactions | RAPGEF6 MYL6 GTPBP6 MYO6 USP9X SPTBN1 ERBIN NDUFS1 ADCY9 SEPTIN2 RFTN1 NDRG1 MRC2 DLG3 ATP13A3 DIAPH3 UTRN IGSF3 FAT4 ADGRL1 LRRC8D CDC42BPB TGFBR1 LRRC8A MACF1 DAAM1 PARD3 MAP2K1 | 4.93e-05 | 840 | 296 | 28 | int:RHOB |
| Interaction | C3orf18 interactions | 5.08e-05 | 115 | 296 | 9 | int:C3orf18 | |
| Interaction | USP11 interactions | CAND1 MYL6 MYCBP2 MYO6 SPTBN1 HSPH1 KEAP1 ERBIN NDUFS1 ADD1 DHX15 FBXO38 FASN BRCA1 BRCA2 HSPA4 DYNC1H1 HSPA4L XPC TGFBR1 MTOR | 5.20e-05 | 539 | 296 | 21 | int:USP11 |
| Interaction | HNRNPA2B1 interactions | ATXN2L CAND1 MYCBP2 HSPH1 CKAP5 NDN SSRP1 NEDD4 BRCA1 PER2 STARD9 AP1M1 DDX39B EPS8L2 SAE1 PDIA3 CUL5 LIG4 PPP2R5C CELF1 MACF1 PRKD1 SLFN11 DOT1L TP53BP1 AHNAK2 | 5.32e-05 | 754 | 296 | 26 | int:HNRNPA2B1 |
| Interaction | ZUP1 interactions | VPS11 CAND1 BLM FASN UTRN DYNC1H1 IPO5 RELCH POLR2B VPS54 MTOR | 5.51e-05 | 174 | 296 | 11 | int:ZUP1 |
| Interaction | BRCA2 interactions | ATR KEAP1 SSRP1 NEDD4 BRCA1 BRCA2 ANAPC2 MMP10 HSPA4 DYNC1H1 RELCH SAE1 CARD8 TP63 TTI1 POLQ TP53BP1 | 5.83e-05 | 384 | 296 | 17 | int:BRCA2 |
| Interaction | MEX3A interactions | ERP44 USP9X SPTBN1 CKAP5 FASN AHNAK PEX19 DDX39B DYNC1H1 IPO5 ANK1 SAE1 CDC42BPB CELF1 MACF1 ALPK2 AHNAK2 | 5.83e-05 | 384 | 296 | 17 | int:MEX3A |
| Interaction | KDM1A interactions | USP34 VPS11 GAPVD1 RAPGEF6 ERP44 MYCBP2 USP9X ZGRF1 LIN54 CKAP5 KEAP1 MCCC1 COPS2 NDUFS1 DHX15 FASN BRCA1 BRCA2 ANAPC1 AHNAK CHD6 DIAPH3 TASOR UTRN GPRASP2 DNAJC13 POLR2B ARAF LRP1 TP53BP1 | 5.95e-05 | 941 | 296 | 30 | int:KDM1A |
| Interaction | ARL14 interactions | 6.64e-05 | 119 | 296 | 9 | int:ARL14 | |
| Interaction | UBE2L3 interactions | USP34 VPS11 TRAF6 MYCBP2 USP9X NEDD4 BRCA1 HSPA4 CUL5 LIG4 HERC4 TP53BP1 | 7.11e-05 | 211 | 296 | 12 | int:UBE2L3 |
| Interaction | PLK1 interactions | GAPVD1 MYCBP2 FBXL5 NEDD4 STIM1 BRCA1 BRCA2 ANAPC1 ANAPC2 HSPA4 DDX39B GPRASP2 RELCH USP16 PDIA3 KLHL22 ANKRD44 MTOR PARD3 TP53BP1 | 7.18e-05 | 510 | 296 | 20 | int:PLK1 |
| Interaction | RHOH interactions | MYO5A MYO6 USP9X SPTBN1 ERBIN NDUFS1 ADCY9 ADD1 STIM1 SEMA6A IGSF3 RELCH SAE1 CDC42BPB TGFBR1 MTOR LRRC8A DAAM1 PARD3 LRIF1 | 7.57e-05 | 512 | 296 | 20 | int:RHOH |
| Interaction | GSK3B interactions | GAPVD1 TRAF6 RAPGEF6 MYL6 DISC1 HSPH1 KEAP1 HMOX2 SSRP1 COPS2 ERBIN NDUFS1 ADD1 FASN NDRG1 PEX5 AKT2 CHD6 UTRN HSPA4 IPO5 MIA3 DNAJC13 STON1 PDIA3 NHSL1 MTOR MACF1 | 8.67e-05 | 868 | 296 | 28 | int:GSK3B |
| Interaction | GALNTL5 interactions | 1.05e-04 | 7 | 296 | 3 | int:GALNTL5 | |
| Interaction | MUSK interactions | 1.07e-04 | 74 | 296 | 7 | int:MUSK | |
| Interaction | YWHAQ interactions | ATXN2L TRAF6 RAPGEF6 HIVEP2 MYCBP2 DISC1 HSPH1 DAPK1 MCCC1 NEB ERBIN NEDD4 FASN BRCA1 STARD9 UNC79 HSPA4 DYNC1H1 SEC23B ARAP2 HNRNPUL1 ARAF LPIN3 NHSL1 MTOR MACF1 CD74 PRKD1 SLFN11 SSH2 PARD3 CABIN1 MAP2K1 | 1.11e-04 | 1118 | 296 | 33 | int:YWHAQ |
| Interaction | CD274 interactions | TBRG4 CAND1 ATR USP9X HSPH1 CKAP5 NEDD4 SEPTIN2 FASN PEX19 SEC23B IPO5 PDIA3 ORC4 MTOR TTI1 | 1.22e-04 | 369 | 296 | 16 | int:CD274 |
| Interaction | TGFBR1 interactions | TRAF6 SPTBN1 ACVR2B STK35 NEDD4 FASN ECEL1 HSPA4 ANK1 CUL5 TGFBR1 TP63 LRP1 | 1.22e-04 | 258 | 296 | 13 | int:TGFBR1 |
| Interaction | RAB35 interactions | GAPVD1 MYO5A SPTBN1 HMOX2 ERBIN ADCY9 ADD1 STIM1 RFTN1 NDRG1 IFITM3 AKT2 ATP13A3 DIAPH3 REEP5 UTRN IGSF3 CDC42BPB SBF2 MACF1 PARD3 | 1.23e-04 | 573 | 296 | 21 | int:RAB35 |
| Interaction | LOXL2 interactions | MYL6 ERP44 MYO5A SPTBN1 HSPH1 DAPK1 SSRP1 DHX15 FASN BRCA1 AHNAK ECEL1 PDIA3 LGALS3BP TP63 LRP1 MACF1 | 1.29e-04 | 410 | 296 | 17 | int:LOXL2 |
| Interaction | RAC3 interactions | INHBA SPTBN1 ERBIN ADCY9 ADD1 STIM1 NDRG1 DLG3 ATP13A3 DIAPH3 UTRN IGSF3 ARAP2 RELCH FAT4 ADGRL1 CDC42BPB TGFBR1 LRRC8A MACF1 DAAM1 PARD3 | 1.32e-04 | 619 | 296 | 22 | int:RAC3 |
| Interaction | CFTR interactions | ATXN2L ABCC4 CAND1 MYL6 MYO6 INHBA USP9X ZGRF1 SPTBN1 HSPH1 MCCC1 ERBIN NDUFS1 RYR2 NEDD4 FANCB FASN IL1R2 AHNAK TOR1B HSPA4 DYNC1H1 SEC23B PNP IPO5 COL9A1 HSPA4L PCDHB8 SAE1 HNRNPUL1 IPO4 PDIA3 LGALS3BP KLHL22 PTCD1 MTOR TTI1 MACF1 DAAM1 TP53BP1 | 1.35e-04 | 1480 | 296 | 40 | int:CFTR |
| Interaction | FKBP5 interactions | EPHB6 ATR PDK2 STK35 FASN ANAPC1 AKT2 NR3C2 PRR14L HSPA4 IPO5 REXO5 POLR2B ARAF PPP2R5C TTI1 MAP2K1 | 1.45e-04 | 414 | 296 | 17 | int:FKBP5 |
| Interaction | GPR45 interactions | TBRG4 SPG7 ATR TUBGCP2 DGLUCY PEX19 ATP13A3 SLC30A9 VPS8 TGFBR1 CCZ1 MTOR TTI1 METTL15 | 1.52e-04 | 300 | 296 | 14 | int:GPR45 |
| Interaction | SEMA4C interactions | 1.53e-04 | 163 | 296 | 10 | int:SEMA4C | |
| Interaction | PPP1R9B interactions | CAND1 MYL6 MYO5A MYCBP2 MYO6 RPS6KA2 SPTBN1 HSPH1 CKAP5 NDUFS1 ADD1 FASN BRCA1 IFITM3 SYN1 DLG3 HSPA4 DYNC1H1 RELCH HSPA4L PDIA3 MAP2K1 | 1.54e-04 | 626 | 296 | 22 | int:PPP1R9B |
| Interaction | TERF2 interactions | USP9X HSPH1 CKAP5 SSRP1 RYR2 BLM BRCA1 BRCA2 UTRN HSPA4 HSPA4L LIG4 RASGEF1C MACF1 TP53BP1 | 1.64e-04 | 340 | 296 | 15 | int:TERF2 |
| Interaction | CDC5L interactions | UTP6 STK36 CAND1 ATR DISC1 SPTBN1 CKAP5 TUBGCP2 COPS2 DHX15 FASN BRCA1 ANAPC1 SUPV3L1 AHNAK ANAPC2 DDX39B DYNC1H1 IPO5 CCZ1B EPS8L2 GRB14 ORC4 CCZ1 MACF1 SLFN11 DOT1L | 1.64e-04 | 855 | 296 | 27 | int:CDC5L |
| Interaction | LGALS9 interactions | ABCC4 CAND1 MYL6 USP9X SPTBN1 MCCC1 HMOX2 SSRP1 FASN MRC2 ATP13A3 DYNC1H1 SEC23B IGSF3 IPO5 DNAJC13 GTPBP10 PDIA3 LGALS3BP LRP1 LRRC8A | 1.75e-04 | 588 | 296 | 21 | int:LGALS9 |
| Interaction | RHOA interactions | MYO6 USP9X SPTBN1 HMOX2 ERBIN NDUFS1 ADCY9 STIM1 CSGALNACT2 IFITM3 MRC2 DLG3 ATP13A3 DIAPH3 SLC30A9 REEP5 UTRN IGSF3 ARAP2 FAT4 MIA3 IFT22 ADGRL1 IPO4 LRRC8D CDC42BPB TGFBR1 MRPS2 TP63 LRRC8A MACF1 DAAM1 PARD3 MAP2K1 | 1.85e-04 | 1199 | 296 | 34 | int:RHOA |
| Interaction | CAV1 interactions | CNNM2 TRAF6 RAPGEF6 MYO6 RPS6KA2 SPTBN1 KEAP1 ERBIN ADCY9 ADD1 NEDD4 FASN NDRG1 NR3C2 SEMA6A DIAPH3 UTRN IGSF3 PDIA3 TGFBR1 LRP1 MACF1 PARD3 AHNAK2 | 1.88e-04 | 724 | 296 | 24 | int:CAV1 |
| Interaction | COMTD1 interactions | TBRG4 CAND1 CKAP5 PEX19 DIAPH3 SLC30A9 VPS8 IPO4 MTOR INTS4 TTI1 | 1.90e-04 | 200 | 296 | 11 | int:COMTD1 |
| Interaction | RHOG interactions | SPG7 USP9X SPTBN1 HMOX2 ERBIN NDUFS1 ADCY9 ADD1 STIM1 NDRG1 IFITM3 DLG3 ATP13A3 DIAPH3 SLC30A9 IGSF3 ADGRL1 GTPBP10 CDC42BPB TGFBR1 MTOR MRPS2 FAM169A LRRC8A MACF1 DAAM1 PARD3 AHNAK2 | 1.91e-04 | 910 | 296 | 28 | int:RHOG |
| Interaction | SYNGAP1 interactions | GPRASP1 ATXN2L CAND1 MYO5A MYCBP2 SPTBN1 SYN1 AP1M1 DLG3 DYNC1H1 BEGAIN MTOR MAP2K1 TP53BP1 | 1.92e-04 | 307 | 296 | 14 | int:SYNGAP1 |
| Interaction | P2RY6 interactions | CAND1 CAND2 HMOX2 TUBGCP2 PEX19 ATP13A3 SLC30A9 REEP5 IPO5 POLR2B VPS8 IPO4 PDIA3 CYRIB LGALS3BP MTOR | 1.98e-04 | 385 | 296 | 16 | int:P2RY6 |
| Interaction | LHX6 interactions | 2.03e-04 | 58 | 296 | 6 | int:LHX6 | |
| Interaction | ARL16 interactions | 2.20e-04 | 83 | 296 | 7 | int:ARL16 | |
| Interaction | RAC1 interactions | TRAF6 MYL6 GTPBP6 MYO6 USP9X SPTBN1 ERBIN NDUFS1 ADCY9 ADD1 NEDD4 STIM1 FASN MRC2 PLCB3 ATP13A3 DIAPH3 UTRN IGSF3 ARAP2 ADGRL1 IPO4 CDC42BPB TGFBR1 MTOR FAM169A LRRC8A MACF1 DAAM1 PARD3 MAP2K1 | 2.23e-04 | 1063 | 296 | 31 | int:RAC1 |
| Interaction | USP2 interactions | TRAF6 DISC1 NEDD4 FASN BRCA1 PER2 AHNAK PEX5 NR3C2 BEGAIN TGFBR1 ARID2 | 2.29e-04 | 239 | 296 | 12 | int:USP2 |
| Interaction | LAMP1 interactions | MYO5A DISC1 SPTBN1 HMOX2 ERBIN ADCY9 ADD1 STIM1 RFTN1 NDRG1 AP1M1 AKT2 PLCB3 ATP13A3 RELCH TGFBR1 ORC4 MTOR LRRC8A TJAP1 MACF1 AHNAK2 | 2.30e-04 | 644 | 296 | 22 | int:LAMP1 |
| Interaction | BAP1 interactions | ATXN2L CAND1 CAND2 MYL6 MYO5A MYCBP2 MYO6 USP9X SPTBN1 HSPH1 CKAP5 KEAP1 SSRP1 COPS2 ADD1 SEPTIN2 DHX15 FASN NDRG1 BRCA1 BRCA2 AHNAK PEX19 HSPA4 DDX39B DYNC1H1 PNP IPO5 HSPA4L POLR2B SAE1 HNRNPUL1 IPO4 PDIA3 MACF1 SLFN11 | 2.31e-04 | 1314 | 296 | 36 | int:BAP1 |
| Interaction | RBX1 interactions | RAPGEF6 CAND1 CAND2 MYL6 MYO5A HSPH1 KEAP1 MCCC1 COPS2 ERBIN FBXL5 NEDD4 DHX15 FBXO38 HSPA4 HSPA4L POLR2B IPO4 NLRP3 CUL5 | 2.38e-04 | 558 | 296 | 20 | int:RBX1 |
| Interaction | TOP3B interactions | USP34 STK36 RAPGEF6 HIVEP2 SPG7 GTPBP6 MYCBP2 MYO6 RPS6KA2 SSRP1 ADCY9 PCNX2 FASN PER2 AHNAK AKT2 DDX39B DYNC1H1 SEC23B WNK2 IGSF3 LRRC8E IPO5 SEMA4B CRYBG2 ADGRL1 IPO4 CDC42BPB LPIN3 NHSL1 C2CD3 CELF1 MTOR SBF2 DOT1L CABIN1 PRRT4 TP53BP1 AHNAK2 | 2.41e-04 | 1470 | 296 | 39 | int:TOP3B |
| Interaction | SCAI interactions | 2.45e-04 | 60 | 296 | 6 | int:SCAI | |
| Interaction | CARD16 interactions | 2.47e-04 | 9 | 296 | 3 | int:CARD16 | |
| Interaction | FGD5 interactions | MYL6 MYO6 SEPTIN2 FASN AHNAK UTRN HSPA4 DYNC1H1 HSPA4L CDC42BPB MACF1 | 2.56e-04 | 207 | 296 | 11 | int:FGD5 |
| Interaction | RUFY1 interactions | GAPVD1 CAND1 MYL6 USP9X HSPH1 MCCC1 TUBGCP2 DHX15 FASN BRCA1 IFITM3 AP1M1 HSPA4 DYNC1H1 HSPA4L AP1M2 IPO4 TTI1 | 2.57e-04 | 476 | 296 | 18 | int:RUFY1 |
| Interaction | GYPA interactions | 2.60e-04 | 174 | 296 | 10 | int:GYPA | |
| Interaction | HSP90B1 interactions | CAND1 GLT1D1 SPTBN1 CKAP5 NDN NDUFS1 NEDD4 STIM1 BRCA1 PER2 BRCA2 DDX39B RELCH XPC CDC42BPB PDIA3 ARAF CUL5 LRP1 LRRC8A DAAM1 DOT1L | 2.61e-04 | 650 | 296 | 22 | int:HSP90B1 |
| Interaction | GGH interactions | ATXN2L GAPVD1 MYCBP2 MYO6 QRICH1 ADGRV1 HMOX2 STIM1 TOR1B EPS8L2 MIA3 LIG4 | 2.67e-04 | 243 | 296 | 12 | int:GGH |
| Interaction | PSMD6 interactions | TRAF6 HSPH1 SSRP1 DHX15 FASN BRCA1 BRCA2 PEX19 DDX39B DYNC1H1 IPO5 ARAF CD74 TP53BP1 | 2.67e-04 | 317 | 296 | 14 | int:PSMD6 |
| Interaction | DIAPH1 interactions | 2.85e-04 | 176 | 296 | 10 | int:DIAPH1 | |
| Interaction | HECTD1 interactions | UTP6 ATXN2L CTU2 CAND1 RNGTT MYO5A MYCBP2 USP9X HSPH1 CKAP5 KEAP1 SSRP1 BLM TASOR UTRN HSPA4 DNAJC13 HSPA4L RNPC3 POLR2B AP1M2 HNRNPUL1 GTPBP10 ARAF ARID2 MACF1 SSH2 RIOK2 METTL15 | 3.00e-04 | 984 | 296 | 29 | int:HECTD1 |
| Interaction | ASF1A interactions | LIN54 BLM FBXO38 FASN BRCA1 BRCA2 CHD6 IPO4 ARID2 DOT1L CABIN1 LRIF1 | 3.33e-04 | 249 | 296 | 12 | int:ASF1A |
| Interaction | CARM1 interactions | CAND1 MYCBP2 HSPH1 DHX15 FASN BRCA1 UTRN DYNC1H1 SEC23B IPO5 CUL5 TP63 DOT1L TP53BP1 | 3.44e-04 | 325 | 296 | 14 | int:CARM1 |
| Interaction | MTHFSD interactions | 3.49e-04 | 10 | 296 | 3 | int:MTHFSD | |
| Interaction | PALB2 interactions | 3.63e-04 | 90 | 296 | 7 | int:PALB2 | |
| Interaction | LDHB interactions | MYCBP2 PDK2 MCF2L2 CKAP5 NDN NDUFS1 FASN BRCA1 ANAPC2 PEX5 DYNC1H1 LIG4 SLFN11 DOT1L | 3.66e-04 | 327 | 296 | 14 | int:LDHB |
| Interaction | ANAPC16 interactions | 3.81e-04 | 65 | 296 | 6 | int:ANAPC16 | |
| Interaction | CUL4A interactions | USP34 CAND1 PDE6A USP9X CKAP5 PBLD KEAP1 SSRP1 COPS2 ADD1 DHX15 STIM1 NDRG1 ANAPC2 AP1M1 PRR14L DDX39B SEC23B MIA3 SEPTIN4 POLR2B HNRNPUL1 NLRP3 LGALS3BP CUL5 MTOR | 3.81e-04 | 854 | 296 | 26 | int:CUL4A |
| Interaction | CGAS interactions | MYO5A MYCBP2 HSPH1 TUBGCP2 NEDD4 FBXO38 BRCA1 IFITM3 VPS35L HSPA4 DNAJC13 HSPA4L MRPS2 LRIF1 | 3.89e-04 | 329 | 296 | 14 | int:CGAS |
| Interaction | NR2C2 interactions | UTP6 TRAF6 TBRG4 CAND1 MYL6 ACSS1 LIN54 HSPH1 KEAP1 MCCC1 SSRP1 NDUFS1 ADD1 DHX15 FASN AHNAK AP1M1 CHD6 HSPA4 DDX39B DYNC1H1 SEC23B ANK1 HSPA4L POLR2B SAE1 HNRNPUL1 IPO4 USP16 ORC4 CELF1 MRPS2 DOT1L MAP2K1 RIOK2 LRIF1 TP53BP1 | 3.94e-04 | 1403 | 296 | 37 | int:NR2C2 |
| GeneFamily | Volume regulated anion channel subunits | 6.51e-08 | 5 | 195 | 4 | 1158 | |
| GeneFamily | Clustered protocadherins | 6.31e-04 | 64 | 195 | 5 | 20 | |
| GeneFamily | Heat shock 70kDa proteins | 7.51e-04 | 17 | 195 | 3 | 583 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 7.91e-04 | 181 | 195 | 8 | 694 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 1.23e-03 | 20 | 195 | 3 | 548 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 1.23e-03 | 20 | 195 | 3 | 736 | |
| GeneFamily | PDZ domain containing | 1.32e-03 | 152 | 195 | 7 | 1220 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | USP34 GAPVD1 CAND1 HIVEP2 RNGTT ATR MYCBP2 USP9X RPS6KA2 CKAP5 DAPK1 ADCY9 NEDD4 BLM DHX15 RFTN1 BRCA1 BRCA2 ATP13A3 TASOR ARAP2 DOP1B MOK DNAJC13 POLR2B C2CD3 PPP2R5C FAM169A MACF1 DAAM1 PARD3 MAP2K1 HERC4 TP53BP1 | 3.04e-10 | 856 | 299 | 34 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | GAPVD1 HIVEP2 RNGTT ATR MYCBP2 USP9X CKAP5 DAPK1 NEDD4 BLM DHX15 RFTN1 BRCA1 ATP13A3 TASOR DOP1B MOK DNAJC13 C2CD3 PPP2R5C FAM169A PARD3 MAP2K1 | 5.05e-09 | 466 | 299 | 23 | M13522 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | VPS11 ABCC4 CAND2 SPG7 ERP44 USP9X RPS6KA2 SPTBN1 HSPH1 UBAP1 DAPK1 COPS2 ERBIN ADD1 STIM1 INTS15 TOR1B ATP13A3 SLC30A9 TASOR HSPA4 DYNC1H1 SEC23B ARAP2 IPO5 CCZ1B MIA3 DNAJC13 SAE1 LRRC8D CARD8 POLR3C CUL5 PPP2R5C GPBP1L1 CELF1 CCZ1 MACF1 DAAM1 | 6.00e-09 | 1215 | 299 | 39 | M41122 |
| Coexpression | RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN | MYO5A INHBA UBAP1 HMOX2 FEM1C CISH AHNAK MMP10 REEP5 PNP LRRC8E LRRC8C SEMA4B CRYBG2 AP1M2 TP63 HERC4 AHNAK2 | 5.20e-07 | 384 | 299 | 18 | M12527 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | USP34 ATXN2L VPS11 GAPVD1 RAPGEF6 HIVEP2 ATR MYO5A MYCBP2 USP9X IL18R1 ERBIN ADD1 NXPE3 SEPTIN2 CISH PCNX2 STIM1 RFTN1 CSGALNACT2 AHNAK AP1M1 TASOR UTRN DYNC1H1 ARAP2 SEMA4D POLR2B CYRIB CARD8 TGFBR1 ANKRD44 PPP2R5C CELF1 ARID2 MACF1 SLFN11 SSH2 MAP2K1 | 1.23e-06 | 1492 | 299 | 39 | M40023 |
| Coexpression | GSE20500_CTRL_VS_RETINOIC_ACID_TREATED_CD4_TCELL_DN | ERP44 MYO6 SPTBN1 IL18R1 PRODH2 CSGALNACT2 SEMA6A SEC23B TBXAS1 SPATA31C2 SHROOM2 DOT1L | 3.19e-06 | 198 | 299 | 12 | M7701 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | USP34 RNGTT ATR CKAP5 FBXO38 BRCA2 ANAPC1 AHNAK ATP13A3 DIAPH3 HSPA4 DNAJC13 USP16 GTPBP10 POLR3C CUL5 TGFBR1 LIG4 CCZ1 RIOK2 HERC4 LRIF1 AHNAK2 | 1.04e-05 | 721 | 299 | 23 | M10237 |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | ATR MYO5A RAPGEF5 TUBGCP2 COPS2 NDUFS1 ADCY9 DHX15 FASN PTPRZ1 IGSF3 DOP1B IPO5 HSPA4L POLR2B TP63 MACF1 TP53BP1 | 1.21e-05 | 481 | 299 | 18 | M3898 |
| Coexpression | KAUFFMANN_DNA_REPAIR_GENES | ATR SSRP1 BLM FANCB BRCA1 BRCA2 XPC LIG4 MTOR TP63 POLQ TP53BP1 | 1.46e-05 | 230 | 299 | 12 | M11563 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | MYO6 LIN54 SPTBN1 ERBIN ADCY9 FANCB CDH20 NDRG1 BRCA1 PTPRZ1 PEX5 HSPA4 LRRC8C SEMA4D COL9A1 IFT22 SEPTIN4 PCDHB13 PCDHB8 SAE1 GRB14 GAS7 SHROOM2 CYRIB ANKRD44 NHSL1 DDX25 TJAP1 CABIN1 PADI2 | 1.55e-05 | 1124 | 299 | 30 | MM1070 |
| Coexpression | GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_DN | USP9X ERBIN NDUFS1 VPS35L HSPA4 DNAJC13 ANK1 RWDD3 MRPS2 DAAM1 LRIF1 | 1.86e-05 | 198 | 299 | 11 | M3248 |
| Coexpression | GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_MIR155_KO_DN | MYO5A LIN54 FBXL5 CSGALNACT2 RNPC3 ORC4 ARID2 RIOK2 METTL15 ZNF654 LRIF1 | 2.04e-05 | 200 | 299 | 11 | M9777 |
| Coexpression | GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_DN | ACSS1 SPTBN1 DAPK1 KEAP1 NDRG1 BRCA1 IFITM3 DYNC1H1 PIF1 SAE1 INTS4 | 2.04e-05 | 200 | 299 | 11 | M7143 |
| Coexpression | GSE17721_POLYIC_VS_CPG_6H_BMDC_DN | MYL6 USP9X CKAP5 ATP13A3 IFT22 RNPC3 GAS7 IPO4 NLRP3 PRKD1 RIOK2 | 2.04e-05 | 200 | 299 | 11 | M3944 |
| Coexpression | GSE557_WT_VS_I_AB_KO_DC_UP | GTPBP6 ACSS1 SPTBN1 MCCC1 NEB FBXO38 REEP5 RELCH MIA3 ARAF KLHL22 | 2.04e-05 | 200 | 299 | 11 | M6009 |
| Coexpression | GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_UP | CTU2 MRPL10 NDUFS1 PEX19 HSPA4 CRYBG2 VPS8 ARAF SLC16A6 PUS10 ALPK2 | 2.04e-05 | 200 | 299 | 11 | M6710 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | MYO6 LIN54 SPTBN1 ERBIN ADCY9 FANCB CDH20 NDRG1 BRCA1 PTPRZ1 PEX5 HSPA4 LRRC8C SEMA4D COL9A1 IFT22 SEPTIN4 PCDHB13 SAE1 GRB14 GAS7 SHROOM2 CYRIB ANKRD44 NHSL1 DDX25 TJAP1 CABIN1 PADI2 | 2.79e-05 | 1102 | 299 | 29 | M2369 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | TRAF6 HIVEP2 INHBA HSPH1 UBAP1 FEM1C COPS2 FBXO38 NDRG1 CSGALNACT2 PER2 MMP10 HSPA4 LRRC8E HSPA4L FICD GPBP1L1 CELF1 FAM169A TJAP1 DAAM1 HERC4 LRIF1 AHNAK2 | 2.81e-05 | 822 | 299 | 24 | M6782 |
| Coexpression | LEE_AGING_NEOCORTEX_UP | 2.85e-05 | 77 | 299 | 7 | M1590 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | GPRASP1 RAPGEF6 MYO5A MYCBP2 RAPGEF5 LIN54 ACVR2B NEB RYR2 CLCN4 DLG3 UNC79 IGSF3 DOP1B MIA3 ANK1 SOBP ADGRL1 GRM1 SHROOM2 ANKRD44 CELF1 LGI2 SBF2 FAM169A SSH2 DAAM1 PRRT4 AHNAK2 | 2.98e-05 | 1106 | 299 | 29 | M39071 |
| Coexpression | LEE_AGING_NEOCORTEX_UP | 4.64e-05 | 83 | 299 | 7 | MM1022 | |
| Coexpression | SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN | TBRG4 RNGTT GTPBP6 MYO5A UBAP1 DHX15 PEX19 UTRN PNP IPO5 SEMA4D POLR2B USP16 ARAF CUL5 ORC4 FICD CCZ1 MAP2K1 | 5.43e-05 | 590 | 299 | 19 | M16066 |
| Coexpression | LAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR | 6.55e-05 | 152 | 299 | 9 | M39243 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | RAPGEF6 ATR MYO5A MYCBP2 MYO6 USP9X HSPH1 BLM CSGALNACT2 BRCA1 DIAPH3 TASOR IPO5 DNAJC13 HSPA4L LIG4 DAAM1 POLQ RIOK2 ZNF654 | 7.36e-05 | 656 | 299 | 20 | M18979 |
| Coexpression | MARTENS_BOUND_BY_PML_RARA_FUSION | HIVEP2 SPG7 INHBA RPS6KA2 ACP5 SPTBN1 TUBGCP2 BLM CISH NDRG1 IFITM3 TBXAS1 GAS7 NLRP3 ARID2 DOT1L | 7.88e-05 | 456 | 299 | 16 | M2094 |
| Coexpression | GSE17322_CD103_POS_VS_CD11B_HIGH_LUNG_DC_UP | 9.08e-05 | 196 | 299 | 10 | M7389 | |
| Coexpression | PARENT_MTOR_SIGNALING_UP | USP34 VPS11 CNNM2 RNGTT PDK2 PDK4 NDUFS1 ADCY9 PRODH2 DGLUCY PEX5 HSPA4 SEPTIN4 MTOR LRP1 PRKD1 CABIN1 SLC25A28 | 1.02e-04 | 567 | 299 | 18 | M16909 |
| Coexpression | GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN | TRAF6 RAPGEF6 MCCC1 NEB CISH NDRG1 IFITM3 AHNAK CRYBG2 TGFBR1 | 1.03e-04 | 199 | 299 | 10 | M8100 |
| Coexpression | GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TREG_DN | RAPGEF6 CAND1 GTPBP6 NEDD4 UTRN KLB HNRNPUL1 SLC13A2 UBXN11 HERC4 | 1.03e-04 | 199 | 299 | 10 | M8805 |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_UP | RAPGEF6 UBAP1 COPS2 DHX15 IL1R2 FLT1 ANK1 USP16 ZNF654 LRIF1 | 1.03e-04 | 199 | 299 | 10 | M7712 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | RAPGEF6 RAPGEF5 SPTBN1 CKAP5 TUBGCP2 BRCA2 DYNC1H1 PIF1 SHROOM2 SSH2 | 1.03e-04 | 199 | 299 | 10 | M5893 |
| Coexpression | GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN | ERP44 FEM1C NDUFS1 NDRG1 BRCA1 ATP13A3 PNP SEMA4D CD74 PADI2 | 1.03e-04 | 199 | 299 | 10 | M5268 |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | DAPK1 MCCC1 IFITM3 IL1R2 PEX5 GPRASP2 IGSF3 AP1M2 ADGRL1 TP53BP1 | 1.03e-04 | 199 | 299 | 10 | M9184 |
| Coexpression | SAGIV_CD24_TARGETS_UP | 1.03e-04 | 22 | 299 | 4 | M4144 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP | SPTBN1 DHX15 CISH ANAPC1 UROD KLHL22 ANKRD44 PPP1R36 PADI2 ZNF654 | 1.07e-04 | 200 | 299 | 10 | M9317 |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP | GPRASP1 RAPGEF6 QRICH1 FBXO38 ANAPC2 ARAP2 MIA3 POLR2B VPS8 MACF1 | 1.07e-04 | 200 | 299 | 10 | M9889 |
| Coexpression | GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_DN | MYL6 DAPK1 SEPTIN2 NDRG1 CSGALNACT2 IL1R2 AHNAK TBXAS1 APIP PADI2 | 1.07e-04 | 200 | 299 | 10 | M4962 |
| Coexpression | GSE21670_UNTREATED_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_UP | PDK4 ACP5 CSGALNACT2 AHNAK UTRN TBXAS1 NLRP3 ANKRD44 UBXN11 LRP1 | 1.07e-04 | 200 | 299 | 10 | M7457 |
| Coexpression | GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP | 1.07e-04 | 200 | 299 | 10 | M7525 | |
| Coexpression | GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN | 1.07e-04 | 200 | 299 | 10 | M5063 | |
| Coexpression | GSE5679_RARA_AGONIST_AM580_VS_AM580_AND_ROSIGLITAZONE_TREATED_DC_DN | RAPGEF6 ACP5 NEB ADD1 CISH DGLUCY NDRG1 IFITM3 UBXN11 LRRC8A | 1.07e-04 | 200 | 299 | 10 | M6570 |
| Coexpression | GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_UP | USP34 FEM1C UTRN PNP RELCH HSPA4L VPS54 PPP2R5C METTL15 LRIF1 | 1.07e-04 | 200 | 299 | 10 | M6584 |
| Coexpression | GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | RAPGEF6 MYO5A USP9X BLM SUPV3L1 REEP5 HSPA4 CYRIB ZNF654 LRIF1 | 1.07e-04 | 200 | 299 | 10 | M6993 |
| Coexpression | ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN | MAGEA2 GAPVD1 MYO5A DISC1 ADGRV1 ADD1 TRPV3 WNK2 ACSS3 COL9A1 CRYBG2 NRAP ANK1 OBP2A VPS8 SPATA31C2 GRB14 WDFY4 NLRP3 TMEM132D SBF2 RASGEF1C MAP2K1 | 1.90e-04 | 873 | 299 | 23 | M16009 |
| Coexpression | GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN | 1.91e-04 | 175 | 299 | 9 | M6694 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR | CAND2 RAPGEF5 DAPK1 NDN MCCC1 HMOX2 FASN PER2 DLG3 HSPA4 GPRASP2 IFT22 OBP2A IPO4 RWDD3 LGALS3BP MTOR RBBP9 | 2.05e-04 | 600 | 299 | 18 | MM1025 |
| Coexpression | GSE14415_INDUCED_TREG_VS_FAILED_INDUCED_TREG_DN | 2.17e-04 | 178 | 299 | 9 | M2952 | |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | SPTBN1 FREM2 ATP13A3 REEP5 COL9A1 RNPC3 PDIA3 LGALS3BP MACF1 | 2.27e-04 | 179 | 299 | 9 | M39308 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 2.36e-04 | 180 | 299 | 9 | M8239 | |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_LYMPHOID_PRIMED_MPP_DN | 2.46e-04 | 181 | 299 | 9 | M8889 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN | HIVEP2 MYO6 MCCC1 ADGRV1 FBXO38 RFTN1 ARAP2 FAT4 STON1 GRB14 VPS54 CYRIB TP63 ZNF654 LRIF1 AHNAK2 | 2.46e-04 | 504 | 299 | 16 | M2157 |
| Coexpression | GSE9946_IMMATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN | 2.96e-04 | 147 | 299 | 8 | M422 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR | CAND2 RAPGEF5 DAPK1 NDN MCCC1 HMOX2 FASN PER2 DLG3 HSPA4 GPRASP2 IFT22 IPO4 RWDD3 LGALS3BP MTOR RBBP9 | 3.55e-04 | 574 | 299 | 17 | M8215 |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6 | 3.74e-04 | 54 | 299 | 5 | MM537 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | CAND1 SPG7 ERP44 MYCBP2 QRICH1 KEAP1 SSRP1 DHX15 STIM1 ANAPC2 TOR1B UROD SLC30A9 HSPA4 IPO5 CCZ1B DNAJC13 HNRNPUL1 PDIA3 ARAF POLR3C PPP2R5C CCZ1 MTOR MRPS2 MAP2K1 SLC25A28 | 3.77e-04 | 1158 | 299 | 27 | MM1338 |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6 | 4.08e-04 | 55 | 299 | 5 | M1284 | |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | EPHB6 ATR CKAP5 SSRP1 BLM DHX15 BRCA1 BRCA2 DDX39B POLR2B HNRNPUL1 LIG4 PPP2R5C TTI1 | 4.23e-04 | 426 | 299 | 14 | M9516 |
| Coexpression | SASSON_RESPONSE_TO_FORSKOLIN_DN | 4.31e-04 | 85 | 299 | 6 | M12924 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN | 4.31e-04 | 85 | 299 | 6 | M7012 | |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | CAND1 USP9X FEM1C COPS2 FBXL5 SEPTIN2 PEX19 STON1 RWDD3 CUL5 ORC4 PPP2R5C MACF1 PRKD1 | 4.54e-04 | 429 | 299 | 14 | M29 |
| Coexpression | GSE24814_STAT5_KO_VS_WT_PRE_BCELL_UP | 4.58e-04 | 197 | 299 | 9 | M8426 | |
| Coexpression | GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_DN | 4.58e-04 | 197 | 299 | 9 | M8464 | |
| Coexpression | GSE19401_UNSTIM_VS_PAM2CSK4_STIM_FOLLICULAR_DC_UP | 4.58e-04 | 197 | 299 | 9 | M7670 | |
| Coexpression | GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_UP | 4.58e-04 | 197 | 299 | 9 | M5150 | |
| Coexpression | GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_UP | 4.58e-04 | 197 | 299 | 9 | M3136 | |
| Coexpression | GSE12366_GC_BCELL_VS_PLASMA_CELL_UP | 4.58e-04 | 197 | 299 | 9 | M3166 | |
| Coexpression | SASSON_RESPONSE_TO_GONADOTROPHINS_DN | 4.59e-04 | 86 | 299 | 6 | M17143 | |
| Coexpression | GSE22342_CD11C_HIGH_VS_LOW_DECIDUAL_MACROPHAGES_UP | 4.75e-04 | 198 | 299 | 9 | M8131 | |
| Coexpression | GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_UP | MYCBP2 DGLUCY DOP1B LRRC8C RELCH LGALS3BP ANKRD44 LRRC8A INTS4 | 4.75e-04 | 198 | 299 | 9 | M6025 |
| Coexpression | GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_UP | 4.75e-04 | 198 | 299 | 9 | M5222 | |
| Coexpression | GSE3982_BASOPHIL_VS_NKCELL_UP | 4.75e-04 | 198 | 299 | 9 | M5561 | |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_DN | 4.75e-04 | 198 | 299 | 9 | M5776 | |
| Coexpression | GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_UP | 4.93e-04 | 199 | 299 | 9 | M9420 | |
| Coexpression | GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_DN | 4.93e-04 | 199 | 299 | 9 | M9418 | |
| Coexpression | GSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_DN | HIVEP2 FBXL5 CISH IFITM3 POLR2B LGALS3BP ANKRD44 CD74 SLFN11 | 4.93e-04 | 199 | 299 | 9 | M9308 |
| Coexpression | GSE14769_40MIN_VS_360MIN_LPS_BMDM_DN | 4.93e-04 | 199 | 299 | 9 | M3517 | |
| Coexpression | GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN | 4.93e-04 | 199 | 299 | 9 | M9846 | |
| Coexpression | GSE25123_CTRL_VS_IL4_STIM_PPARG_KO_MACROPHAGE_DN | 4.93e-04 | 199 | 299 | 9 | M7976 | |
| Coexpression | GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_DN | 4.93e-04 | 199 | 299 | 9 | M9236 | |
| Coexpression | GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_UP | USP34 RAPGEF6 MYCBP2 ADCY9 NEDD4 SLC30A9 SEPTIN4 TGFBR1 ORC4 | 5.11e-04 | 200 | 299 | 9 | M387 |
| Coexpression | GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_NONATOPIC_PATIENT_UP | 5.11e-04 | 200 | 299 | 9 | M7086 | |
| Coexpression | GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_NONATOPIC_PATIENT_DN | 5.11e-04 | 200 | 299 | 9 | M7080 | |
| Coexpression | GSE27786_CD8_TCELL_VS_ERYTHROBLAST_DN | 5.11e-04 | 200 | 299 | 9 | M4845 | |
| Coexpression | GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_NKTCELL_UP | 5.11e-04 | 200 | 299 | 9 | M8310 | |
| Coexpression | GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP | 5.11e-04 | 200 | 299 | 9 | M7020 | |
| Coexpression | GSE27786_ERYTHROBLAST_VS_MONO_MAC_UP | 5.11e-04 | 200 | 299 | 9 | M4877 | |
| Coexpression | GSE23114_WT_VS_SLE2C1_MOUSE_SPLEEN_B1A_BCELL_UP | 5.11e-04 | 200 | 299 | 9 | M8290 | |
| Coexpression | GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN | MYO5A COPS2 ATP13A3 DYNC1H1 SEC23B DNAJC13 HSPA4L LGALS3BP MACF1 | 5.11e-04 | 200 | 299 | 9 | M3469 |
| Coexpression | GSE33425_CD161_INT_VS_NEG_CD8_TCELL_DN | 5.11e-04 | 200 | 299 | 9 | M8543 | |
| Coexpression | GSE18893_TCONV_VS_TREG_24H_CULTURE_UP | 5.11e-04 | 200 | 299 | 9 | M7290 | |
| Coexpression | GSE18893_CTRL_VS_TNF_TREATED_TCONV_24H_UP | ACTR5 MRPL10 SEPTIN2 DHX15 TOR1B DIAPH3 SLC13A2 APIP METTL15 | 5.11e-04 | 200 | 299 | 9 | M7304 |
| Coexpression | GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_UP | 5.11e-04 | 200 | 299 | 9 | M9953 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_UP | 5.11e-04 | 200 | 299 | 9 | M3636 | |
| Coexpression | GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_UP | 5.11e-04 | 200 | 299 | 9 | M3675 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDC_DN | 5.11e-04 | 200 | 299 | 9 | M4027 | |
| Coexpression | GSE3982_CTRL_VS_LPS_48H_DC_DN | 5.11e-04 | 200 | 299 | 9 | M5377 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP | MRPL10 ADCY9 AHNAK REEP5 ARAP2 TBXAS1 HNRNPUL1 PPP2R5C SLFN11 | 5.11e-04 | 200 | 299 | 9 | M6524 |
| Coexpression | GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_DN | 5.11e-04 | 200 | 299 | 9 | M5225 | |
| Coexpression | GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_UP | RAPGEF6 KEAP1 FBXO38 DOP1B VPS54 LGALS3BP MAP2K1 SLC25A28 RBBP9 | 5.11e-04 | 200 | 299 | 9 | M9051 |
| Coexpression | GSE36078_WT_VS_IL1R_KO_LUNG_DC_DN | 5.11e-04 | 200 | 299 | 9 | M9290 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | ATXN2L RAPGEF6 CAND2 MYCBP2 ZGRF1 HSPH1 FEM1C NDUFS1 NEDD4 FBXO38 FASN TASOR UTRN PIF1 RNPC3 POLR2B VPS54 HNRNPUL1 GTPBP10 CCZ1 ARID2 TTI1 MACF1 RIOK2 RBBP9 | 3.32e-07 | 564 | 293 | 25 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYO6 USP9X SPTBN1 QRICH1 ERBIN NDUFS1 NEDD4 DHX15 AHNAK ARAP2 POLR2B PDIA3 TP63 | 9.80e-10 | 198 | 299 | 13 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYO6 USP9X SPTBN1 QRICH1 ERBIN NDUFS1 NEDD4 DHX15 AHNAK ARAP2 POLR2B PDIA3 TP63 | 9.80e-10 | 198 | 299 | 13 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | GPRASP1 CKAP5 ERBIN RYR2 NEDD4 IGSF10 AHNAK NR3C2 TASOR STON1 HNRNPUL1 MACF1 | 2.84e-09 | 176 | 299 | 12 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e |
| ToppCell | COPD-Myeloid-cMonocyte|COPD / Disease state, Lineage and Cell class | GLT1D1 FCAR NDRG1 CSGALNACT2 IL1R2 SYN1 ATP13A3 TBXAS1 FLT1 GAS7 NLRP3 MAP2K1 | 6.35e-09 | 189 | 299 | 12 | d29f3a0bd23e6eb46389e6eb7ef21851c7b57545 |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | INHBA RAPGEF5 SPTBN1 DAPK1 IL18R1 ADD1 NEDD4 TMEM132C NDRG1 FLT1 MYRIP SHROOM2 | 8.04e-09 | 193 | 299 | 12 | 2531266bc57339d4e2b22a88817008e32b8c1598 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | STK36 MYO7B ADGRV1 NEB RYR2 FREM2 UNC79 FAT4 COL9A1 ANK1 GRM1 | 5.08e-08 | 184 | 299 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | STK36 MYO7B ADGRV1 NEB RYR2 FREM2 UNC79 FAT4 COL9A1 ANK1 GRM1 | 5.08e-08 | 184 | 299 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | STK36 MYO7B ADGRV1 NEB RYR2 FREM2 UNC79 FAT4 COL9A1 ANK1 GRM1 | 5.08e-08 | 184 | 299 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | ABCC4 GAPVD1 MYCBP2 DOP1B MOK PDIA3 ANKRD44 ARID2 MACF1 POLQ ADAT2 | 5.67e-08 | 186 | 299 | 11 | 8571956890fc9894d766ba294a28e376b4aba428 |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | USP34 USP9X HSPH1 ATP13A3 UTRN DYNC1H1 ARAP2 ANKRD44 ARID2 MACF1 TP53BP1 | 6.33e-08 | 188 | 299 | 11 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | HSPH1 NDRG1 CHD6 UTRN HSPA4 ACSS3 VPS54 ARID2 FAM169A PRKD1 DAAM1 | 7.84e-08 | 192 | 299 | 11 | 916fbec1c7ab7969bda711886ac88e877e30c280 |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | ABCC4 MYO6 RAPGEF5 MCCC1 ADGRV1 FREM2 FASN NR3C2 ACSS3 PRKD1 PARD3 | 8.27e-08 | 193 | 299 | 11 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | ABCC4 MYO6 RAPGEF5 MCCC1 ADGRV1 FREM2 FASN NR3C2 ACSS3 PRKD1 PARD3 | 8.27e-08 | 193 | 299 | 11 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | ABCC4 RAPGEF5 MCCC1 ADGRV1 ADCY9 RFTN1 FREM2 FASN NR3C2 PRKD1 PARD3 | 8.71e-08 | 194 | 299 | 11 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf |
| ToppCell | facs-Brain_Non-Myeloid|facs / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYO6 SPTBN1 NEDD4 NDRG1 AHNAK SEMA6A UTRN FLT1 SEPTIN4 GRB14 GAS7 | 1.02e-07 | 197 | 299 | 11 | a1f7eec1aca03432caa8fe817ff6d24b29d4062d |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | GLT1D1 DISC1 FCAR IL1R2 TBXAS1 GAS7 WDFY4 NLRP3 UBXN11 LRP1 MAP2K1 | 1.19e-07 | 200 | 299 | 11 | 5432bdf495431cd26f6e4cd585100f3652588913 |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE|Thalamus / BrainAtlas - Mouse McCarroll V32 | RAB33A CDH20 BRCA1 SEMA6A REEP5 SEC23B SEMA4D COL9A1 USP16 MROH2B | 2.04e-07 | 167 | 299 | 10 | 1e144c03409df94ccd39760842590e8ea7487e29 |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | MYCBP2 IGSF3 ARAP2 RELCH CRYBG2 HSPA4L TP63 LRP1 LRRC8A PARD3 | 3.15e-07 | 175 | 299 | 10 | 0cc215109d9915af47e4d0a120ce2e46910715fa |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | USP34 RAPGEF6 SPG7 AHNAK DDX39B ARAP2 ANKRD44 ARID2 MACF1 HERC4 | 4.30e-07 | 181 | 299 | 10 | f2315414e714ac86211546a935660c4be6e85f1b |
| ToppCell | COPD-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | GLT1D1 FCAR NDRG1 IL1R2 SYN1 ATP13A3 TBXAS1 GAS7 NLRP3 MAP2K1 | 5.00e-07 | 184 | 299 | 10 | ceec41ed5636032aaf7716d1203816ea58bd39bd |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | MYO5A PDK4 MCCC1 ADCY9 NDRG1 SEMA6A PNP SOBP CDC42BPB TGFBR1 | 5.25e-07 | 185 | 299 | 10 | a0a629e5d2b65f670ea907bd3f5e3caf17687d8f |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYO6 RAPGEF5 RPS6KA2 SPTBN1 AHNAK SEMA6A UTRN FLT1 STON1 HNRNPUL1 | 5.52e-07 | 186 | 299 | 10 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 |
| ToppCell | Control-Myeloid-Monocytes|Control / group, cell type (main and fine annotations) | GLT1D1 DISC1 FCAR CSGALNACT2 TBXAS1 GAS7 NLRP3 SBF2 SSH2 MAP2K1 | 6.39e-07 | 189 | 299 | 10 | 3335d16bd0ffa0c1ddd06d7da645299148130c3f |
| ToppCell | COPD-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class | 6.39e-07 | 189 | 299 | 10 | 6294691231c7d38707323cf31578a107d3b2c622 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | USP34 SPTBN1 ERBIN NEDD4 STIM1 NR3C2 TASOR HSPA4L HNRNPUL1 CUL5 | 7.03e-07 | 191 | 299 | 10 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | ABCC4 RAPGEF5 MCCC1 ADGRV1 FREM2 FASN NR3C2 ACSS3 PRKD1 PARD3 | 7.03e-07 | 191 | 299 | 10 | a0332a4ef629510fb313ec119195c44a3f704a80 |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | USP34 SPTBN1 ERBIN NEDD4 STIM1 NR3C2 TASOR HSPA4L HNRNPUL1 CUL5 | 7.03e-07 | 191 | 299 | 10 | 09db184cb90fe282a14474d7217068c58092c6f8 |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | ABCC4 GAPVD1 MYCBP2 IL18R1 DOP1B PDIA3 ANKRD44 ARID2 MACF1 POLQ | 7.03e-07 | 191 | 299 | 10 | 9454f642c3621370fa23640b631301346b300950 |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | USP34 SPTBN1 ERBIN NEDD4 STIM1 NR3C2 TASOR HSPA4L HNRNPUL1 CUL5 | 7.03e-07 | 191 | 299 | 10 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 |
| ToppCell | Control-Myeloid-cMonocyte|Control / Disease state, Lineage and Cell class | GLT1D1 FCAR NDRG1 IL1R2 ATP13A3 TBXAS1 FLT1 GAS7 NLRP3 MAP2K1 | 7.38e-07 | 192 | 299 | 10 | ad04c9c4bdebf94615cee1904ca48197e62c923b |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | USP34 MCF2L2 DAPK1 CD163L1 ATP13A3 UTRN PTCD1 SBF2 SSH2 MAP2K1 | 7.73e-07 | 193 | 299 | 10 | 779276e775cb2492e8dd36436295a536084a6415 |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.73e-07 | 193 | 299 | 10 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 7.73e-07 | 193 | 299 | 10 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Control-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | GLT1D1 FCAR NDRG1 IL1R2 ATP13A3 TBXAS1 FLT1 GAS7 NLRP3 MAP2K1 | 8.11e-07 | 194 | 299 | 10 | f852f5258617a66a4fbd56d64c7b47272e7b8b60 |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | GLT1D1 PDK4 DISC1 FCAR CSGALNACT2 IL1R2 TBXAS1 GAS7 SSH2 MAP2K1 | 8.50e-07 | 195 | 299 | 10 | 81a28289eda1a8a1a31b7357106f64ac5000e172 |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | USP34 MCF2L2 UTRN DDX39B ARAP2 RNPC3 ANKRD44 PPP2R5C FAM169A MACF1 | 9.32e-07 | 197 | 299 | 10 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.02e-06 | 199 | 299 | 10 | b0a906586e58009f5ed9272fc29ba28e49c85ee6 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | USP9X SPTBN1 QRICH1 ERBIN NEDD4 DHX15 AHNAK POLR2B PDIA3 TP63 | 1.02e-06 | 199 | 299 | 10 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-06 | 200 | 299 | 10 | b4277b6faa69f20974696c7c422311f5c89e3663 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.56e-06 | 162 | 299 | 9 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | RAPGEF5 MCF2L2 IL18R1 TMEM132C RFTN1 STARD9 SEPTIN4 PCDHB13 ABCC12 | 1.73e-06 | 164 | 299 | 9 | f6a961fa2002da7d9679f32af99e1314c0593ef9 |
| ToppCell | LPS-antiTNF-Endothelial-Mes-Like-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.91e-06 | 166 | 299 | 9 | 3b750d4023a0a09d86113aae5a97d84391f7b482 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-06 | 175 | 299 | 9 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | Children_(3_yrs)|World / Lineage, Cell type, age group and donor | 3.39e-06 | 178 | 299 | 9 | df2ecd3214590b914f2762db57efe780ba038db3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.54e-06 | 179 | 299 | 9 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.88e-06 | 181 | 299 | 9 | 062f00736eed96e4f4327615d093558dd7d82b20 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.06e-06 | 182 | 299 | 9 | dc32f8f6a3b13918eb8e93c018f5823d86344080 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-06 | 182 | 299 | 9 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-06 | 182 | 299 | 9 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.13e-06 | 137 | 299 | 8 | 80f1a6cfb48ccfba1c3545fdcd5fcb3157272aca | |
| ToppCell | COVID-19-APC-like|COVID-19 / group, cell type (main and fine annotations) | 4.24e-06 | 183 | 299 | 9 | b8f5afaf9ff1b2b1bc60be58654d1b23859dafa9 | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 4.44e-06 | 184 | 299 | 9 | 7fd0b227c3750ffb80e41e92c60fcce46656be14 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 4.64e-06 | 185 | 299 | 9 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.64e-06 | 185 | 299 | 9 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic-CD1c-positive_myeloid_dendritic_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.85e-06 | 186 | 299 | 9 | 0dce13e15c3bf32610bf2dad31253b52a39cff87 | |
| ToppCell | facs-Heart-Unknown-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-06 | 187 | 299 | 9 | c004567767b89f3d89f5c7b28d952f3445957e1e | |
| ToppCell | facs-Heart-Unknown|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-06 | 187 | 299 | 9 | 362e56426a568423a81e8a30e3ecf99b76135843 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.06e-06 | 187 | 299 | 9 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | INHBA RAPGEF5 SPTBN1 DAPK1 TMEM132C ATP13A3 FLT1 MYRIP SHROOM2 | 5.52e-06 | 189 | 299 | 9 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.76e-06 | 190 | 299 | 9 | 31de1727822e9818652946dfb962daee77ffad68 | |
| ToppCell | IPF-Myeloid-cMonocyte|IPF / Disease state, Lineage and Cell class | 5.76e-06 | 190 | 299 | 9 | a099f51f2b7618b6712af38eedd5ee64d8663a4a | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.76e-06 | 190 | 299 | 9 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | COPD-Myeloid-cDC2|World / Disease state, Lineage and Cell class | 6.01e-06 | 191 | 299 | 9 | 4e4887175200a57e1b041f2f131e3df774df3509 | |
| ToppCell | Control-Myeloid|Control / group, cell type (main and fine annotations) | 6.01e-06 | 191 | 299 | 9 | 9c4acc5f3c2f9c0c5520863bb22f391774372347 | |
| ToppCell | LV-08._Macrophage|LV / Chamber and Cluster_Paper | 6.27e-06 | 192 | 299 | 9 | 7be12d580aaf2f2f1562203fcad3a44639b8c5a6 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-06 | 192 | 299 | 9 | ec1fd2fb6e71f87189d66261909a84e2be63cacb | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 6.27e-06 | 192 | 299 | 9 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 6.27e-06 | 192 | 299 | 9 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Control-Myeloid-Monocyte-derived_macrophages|Control / group, cell type (main and fine annotations) | 6.54e-06 | 193 | 299 | 9 | a6b3bd01e585e2e3fbe9bf693a2e385773123f8e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.54e-06 | 193 | 299 | 9 | 40edc07b6e7f19f6ee885fa5af0b63ef1b0f2468 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 6.54e-06 | 193 | 299 | 9 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.54e-06 | 193 | 299 | 9 | b03d908d4b8940927f72c76a1b0f237d13f39056 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.81e-06 | 194 | 299 | 9 | 590a9d4f054e6a3685daf752c9354650fcc7d18a | |
| ToppCell | LA-08._Macrophage|World / Chamber and Cluster_Paper | 6.81e-06 | 194 | 299 | 9 | c1805572bcc11b1cd29083329d7b5911489fb758 | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 6.95e-06 | 147 | 299 | 8 | a21b63d0d3aec9ffadf3fac833a0a24da58a95bf | |
| ToppCell | COVID-19-Myeloid-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations) | 7.10e-06 | 195 | 299 | 9 | c172c5599379c29123340621a36bfb1fc90c2115 | |
| ToppCell | LA-08._Macrophage|LA / Chamber and Cluster_Paper | 7.10e-06 | 195 | 299 | 9 | 5e1d5bdb8874091f5a2b1d0a8cc9008165718a97 | |
| ToppCell | CF-Myeloid|CF / Disease state, Lineage and Cell class | GLT1D1 FBXL5 FCAR CSGALNACT2 IFITM3 IL1R2 ATP13A3 TBXAS1 SBF2 | 7.10e-06 | 195 | 299 | 9 | ecf604de496f389a49429d0bb211e1db6019cc8b |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 7.10e-06 | 195 | 299 | 9 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-DC-cDC2-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.10e-06 | 195 | 299 | 9 | a2fe352682f548001ca2ee056e7a54af10134453 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 7.10e-06 | 195 | 299 | 9 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | MYO6 RAPGEF5 RPS6KA2 SPTBN1 NEDD4 STARD9 SEMA6A FLT1 SHROOM2 | 7.40e-06 | 196 | 299 | 9 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.40e-06 | 196 | 299 | 9 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | MYO6 RAPGEF5 RPS6KA2 SPTBN1 NEDD4 STARD9 SEMA6A FLT1 SHROOM2 | 7.40e-06 | 196 | 299 | 9 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.71e-06 | 197 | 299 | 9 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.71e-06 | 197 | 299 | 9 | dea1d29154c585ab588e50b83c7c8de7fe24d2d4 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.71e-06 | 197 | 299 | 9 | 8af4a1e35ce9fb4ea3d26ab619599efb7eac43a5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.71e-06 | 197 | 299 | 9 | 6ca6e17b7cc5f7ea8d4b6ca1ff670969bee65a45 | |
| ToppCell | Monocytes-NUPR1+_Monocytes|Monocytes / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.71e-06 | 197 | 299 | 9 | 8a058c9d9285acd7cf2fb8e34f7602a86b5d6c89 | |
| ToppCell | COVID-19-Myeloid|COVID-19 / group, cell type (main and fine annotations) | 8.03e-06 | 198 | 299 | 9 | 33f0a919188a67d2a876b52c61a1cec2c9747969 | |
| ToppCell | ASK440|World / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.03e-06 | 198 | 299 | 9 | f3ed6efd521c691debae32a803972bed5d069332 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.03e-06 | 198 | 299 | 9 | c7dbf24caae5c4ef285845d13055de9e07281bb3 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.03e-06 | 198 | 299 | 9 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | nucseq-Immune-Immune_Myeloid-iMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.03e-06 | 198 | 299 | 9 | bf5806424be33790f78f1c160398046a8725e469 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.03e-06 | 198 | 299 | 9 | 2b724d2a36843801984d46a969d33149b76c9771 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-iMON-iMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.03e-06 | 198 | 299 | 9 | e6dad9dea8cbd368b1b127572212cc913b909ffe | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 8.36e-06 | 199 | 299 | 9 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.71e-06 | 200 | 299 | 9 | 179afc4bee7a2fd85a3b5dadf32544a63807c164 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.71e-06 | 200 | 299 | 9 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.71e-06 | 200 | 299 | 9 | 347a510755374c6a66acee326565dfc447993f18 | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; PC3; HT_HG-U133A | CNNM2 RPS6KA2 HMOX2 NEB RYR2 NR3C2 TBXAS1 FAT4 SOBP GAS7 ADGRL1 KLHL22 LRP1 TJAP1 | 3.27e-07 | 197 | 296 | 14 | 6663_DN |
| Drug | Diflunisal [22494-42-4]; Down 200; 16uM; MCF7; HT_HG-U133A | ERP44 ACTR5 PDK2 ADCY9 RFTN1 FGD1 ATP13A3 ARAP2 ADGRL1 XPC CYRIB MACF1 PARD3 HERC4 | 3.94e-07 | 200 | 296 | 14 | 1490_DN |
| Drug | Tropine [120-29-6]; Down 200; 28.4uM; PC3; HT_HG-U133A | USP34 GPRASP1 RAPGEF5 PDK2 RYR2 PCNX2 DLG3 PRR14L UROD IGSF3 CARD8 KLHL22 TJAP1 | 2.11e-06 | 198 | 296 | 13 | 5790_DN |
| Drug | Nocodazole [31430-18-9]; Down 200; 13.2uM; PC3; HT_HG-U133A | TRAF6 TBRG4 CAND2 RNGTT PCNX2 FGD1 DLG3 CYRIB PPP2R5C DAAM1 ZNF654 RBBP9 | 7.74e-06 | 190 | 296 | 12 | 7145_DN |
| Drug | Thiethylperazine malate [52239-63-1]; Down 200; 6uM; MCF7; HT_HG-U133A | CNNM2 RNGTT HMOX2 ACVR2B BRCA1 INTS15 PEX19 PRR14L ATP13A3 SEMA4D ADGRL1 LGALS3BP | 1.12e-05 | 197 | 296 | 12 | 6232_DN |
| Drug | Aconitine [302-27-2]; Down 200; 6.2uM; PC3; HT_HG-U133A | CAND2 RNGTT PDK2 PBLD HMOX2 NEDD4 ANAPC2 FGD1 DOP1B CARD8 CUL5 LIG4 | 1.12e-05 | 197 | 296 | 12 | 7149_DN |
| Drug | Nafronyl oxalate [3200-06-4]; Down 200; 8.4uM; PC3; HT_HG-U133A | CAND2 ERP44 PDK4 FBXL5 PER2 TMEM231 IGSF3 FAT4 ADGRL1 SHROOM2 POLQ CABIN1 | 1.17e-05 | 198 | 296 | 12 | 6687_DN |
| Drug | Magnetite Nanoparticles | USP34 CAND1 USP9X RPS6KA2 ACP5 BLM FANCB NDRG1 CSGALNACT2 BRCA1 PER2 BRCA2 ANAPC1 STARD9 AHNAK SYN1 ATP13A3 MMP10 UTRN HSPA4 IGSF3 TBXAS1 LRRC8C MIA3 USP16 CYRIB NLRP3 TGFBR1 ANKRD44 LIG4 DDX25 LRP1 CD74 DAAM1 PADI2 AHNAK2 | 1.87e-05 | 1310 | 296 | 36 | ctd:D058185 |
| Drug | Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | USP34 HSPH1 NEB ERBIN FBXL5 TASOR ARAP2 HSPA4L VPS54 FAM169A HERC4 | 2.52e-05 | 180 | 296 | 11 | 2859_DN |
| Drug | sebacate | 2.65e-05 | 181 | 296 | 11 | CID000005192 | |
| Drug | Succimer | USP34 CAND1 USP9X RPS6KA2 ACP5 BLM FANCB NDRG1 CSGALNACT2 BRCA1 BRCA2 ANAPC1 STARD9 AHNAK SYN1 ATP13A3 MMP10 UTRN HSPA4 IGSF3 TBXAS1 LRRC8C MIA3 USP16 CYRIB NLRP3 TGFBR1 ANKRD44 LIG4 LRP1 CD74 DAAM1 PADI2 AHNAK2 | 4.98e-05 | 1264 | 296 | 34 | ctd:D004113 |
| Drug | Sertaconazole nitrate [99592-39-9]; Down 200; 8uM; MCF7; HT_HG-U133A | USP34 PDK2 RPS6KA2 SPTBN1 INTS15 PLCB3 GAS7 ARAF CARD8 PPP2R5C PARD3 | 5.00e-05 | 194 | 296 | 11 | 6811_DN |
| Drug | Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; PC3; HT_HG-U133A | CNNM2 RAPGEF5 ADCY9 PCNX2 BRCA2 PEX5 PLCB3 ATP13A3 NOVA2 SEMA4D CABIN1 | 5.24e-05 | 195 | 296 | 11 | 5763_DN |
| Drug | Lumicolchicine gamma [6901-14-0]; Down 200; 10uM; MCF7; HT_HG-U133A | USP34 CNNM2 RNGTT RPS6KA2 FBXO38 PLCB3 MOK IPO5 MTOR TJAP1 PARD3 | 5.24e-05 | 195 | 296 | 11 | 3254_DN |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A | DISC1 SPTBN1 PCNX2 CLCN4 MRC2 AHNAK BEGAIN ANK1 LIG4 TP63 AHNAK2 | 5.48e-05 | 196 | 296 | 11 | 2310_UP |
| Drug | LY 294002; Down 200; 10uM; HL60; HT_HG-U133A | ATXN2L INHBA ADCY9 NEDD4 PER2 IL1R2 AHNAK MINAR1 GRM1 LIG4 PADI2 | 5.48e-05 | 196 | 296 | 11 | 2687_DN |
| Drug | Folic acid [59-30-3]; Down 200; 9uM; HL60; HG-U133A | USP34 CNNM2 TRAF6 CAND1 MYCBP2 HMOX2 CISH DGLUCY SEC23B MIA3 PARD3 | 5.48e-05 | 196 | 296 | 11 | 1790_DN |
| Drug | alpha-estradiol; Down 200; 0.01uM; HL60; HT_HG-U133A | ATXN2L RNGTT CLCN4 MINAR1 PLCB3 TMEM231 HSPA4 ARAP2 SEMA4D VPS54 CABIN1 | 5.74e-05 | 197 | 296 | 11 | 6169_DN |
| Drug | Aztreonam [78110-38-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A | CNNM2 RNGTT RPS6KA2 SPTBN1 FBXO38 FGD1 DLG3 IPO5 GAS7 ADGRL1 PARD3 | 5.74e-05 | 197 | 296 | 11 | 2282_DN |
| Drug | Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A | ATXN2L CNNM2 MYO6 RPS6KA2 NEB CLCN4 AHNAK MINAR1 ARAP2 LIG4 PADI2 | 5.74e-05 | 197 | 296 | 11 | 2702_DN |
| Drug | Harmol hydrochloride monohydrate [40580-83-4]; Up 200; 15.8uM; HL60; HG-U133A | USP34 CNNM2 ATR FEM1C COPS2 PER2 FGD1 UTRN IPO5 LGALS3BP PARD3 | 5.74e-05 | 197 | 296 | 11 | 1750_UP |
| Drug | (+/-)-verapamil hydrochloride; Down 200; 10uM; MCF7; HG-U133A | GAPVD1 TBRG4 SPG7 MYCBP2 MYO6 UBAP1 CISH INTS15 ATP13A3 RIOK2 LRIF1 | 5.74e-05 | 197 | 296 | 11 | 161_DN |
| Drug | Niacin [59-67-6]; Down 200; 32.4uM; MCF7; HT_HG-U133A | ABCC4 CNNM2 ACVR2B RFTN1 BRCA2 ARAP2 SEMA4D DNAJC13 ADGRL1 ARAF CUL5 | 5.74e-05 | 197 | 296 | 11 | 5301_DN |
| Drug | Melatonin [73-31-4]; Up 200; 17.2uM; HL60; HT_HG-U133A | GPRASP1 PDK2 ADCY9 NXPE3 FCAR CLCN4 MRC2 DLG3 STON1 AP1M2 GRM1 | 6.01e-05 | 198 | 296 | 11 | 2431_UP |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | ERP44 TUBGCP2 RFTN1 NDRG1 DLG3 TMEM231 HSPA4 IPO5 SOBP KLHL22 POLQ | 6.01e-05 | 198 | 296 | 11 | 1669_DN |
| Drug | Pyrilamine maleate [59-33-6]; Down 200; 10uM; PC3; HT_HG-U133A | USP34 RNGTT SPTBN1 NXPE3 DLG3 IGSF3 IPO5 SEMA4D IFT22 AP1M2 ADGRL1 | 6.01e-05 | 198 | 296 | 11 | 5869_DN |
| Drug | Bemegride [64-65-3]; Down 200; 25.8uM; PC3; HT_HG-U133A | RPS6KA2 SPTBN1 NEB FGD1 UROD IGSF3 SEMA4D STON1 TJAP1 PRKD1 CABIN1 | 6.01e-05 | 198 | 296 | 11 | 6668_DN |
| Drug | Naloxone hydrochloride [357-08-4]; Down 200; 11uM; MCF7; HT_HG-U133A | GPRASP1 HIVEP2 MYL6 PCNX2 FGD1 PEX5 PLCB3 GAS7 CYRIB CABIN1 PADI2 | 6.01e-05 | 198 | 296 | 11 | 1506_DN |
| Drug | Chlorogenic acid [327-97-9]; Down 200; 11.2uM; HL60; HT_HG-U133A | EPHB6 HIVEP2 ACTR5 RYR2 IL1R2 INTS15 TBXAS1 TGFBR1 FICD TJAP1 PARD3 | 6.01e-05 | 198 | 296 | 11 | 1346_DN |
| Drug | Oxybutynin chloride [1508-65-2]; Up 200; 10.2uM; HL60; HG-U133A | CNNM2 ERP44 CISH IFITM3 SEC23B LGALS3BP KLHL22 CUL5 ORC4 PPP2R5C PARD3 | 6.01e-05 | 198 | 296 | 11 | 1551_UP |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; MCF7; HT_HG-U133A | CNNM2 PDK2 FBXO38 FGD1 PEX5 ADGRL1 LGALS3BP KLHL22 CUL5 MTOR ZNF654 | 6.29e-05 | 199 | 296 | 11 | 1488_DN |
| Drug | Vitamin K2 [11032-49-8]; Down 200; 9uM; PC3; HT_HG-U133A | USP34 MYO6 RAPGEF5 RPS6KA2 DOP1B TBXAS1 SEMA4D REXO5 ADGRL1 KLHL22 TJAP1 | 6.29e-05 | 199 | 296 | 11 | 4534_DN |
| Drug | Azlocillin sodium salt [37091-65-9]; Down 200; 8.2uM; PC3; HT_HG-U133A | MYO6 RYR2 CISH PEX5 TMEM231 UTRN REXO5 SOBP KLHL22 TJAP1 CABIN1 | 6.29e-05 | 199 | 296 | 11 | 5788_DN |
| Drug | AC1L18R8 | 6.95e-05 | 105 | 296 | 8 | CID000050261 | |
| Disease | cancer (implicated_via_orthology) | CAND1 CAND2 SSRP1 BRCA2 DLG3 AKT2 PIF1 IPO5 FLT1 ARAF MTOR TP63 TTI1 MACF1 MAP2K1 | 7.54e-08 | 268 | 289 | 15 | DOID:162 (implicated_via_orthology) |
| Disease | Adenocarcinoma of lung (disorder) | 6.59e-06 | 206 | 289 | 11 | C0152013 | |
| Disease | ovarian neoplasm | 7.34e-06 | 134 | 289 | 9 | C0919267 | |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 8.53e-06 | 29 | 289 | 5 | C0496920 | |
| Disease | Malignant neoplasm of ovary | 8.79e-06 | 137 | 289 | 9 | C1140680 | |
| Disease | Ovarian Carcinoma | 1.02e-05 | 30 | 289 | 5 | C0029925 | |
| Disease | Non-Small Cell Lung Carcinoma | 2.49e-05 | 156 | 289 | 9 | C0007131 | |
| Disease | Malignant Neoplasms | 3.98e-05 | 128 | 289 | 8 | C0006826 | |
| Disease | ductal carcinoma in situ (biomarker_via_orthology) | 9.56e-05 | 2 | 289 | 2 | DOID:0060074 (biomarker_via_orthology) | |
| Disease | Hereditary site-specific ovarian cancer syndrome | 9.56e-05 | 2 | 289 | 2 | C4749652 | |
| Disease | Malignant neoplasm of breast | CTU2 MCF2L2 KEAP1 FEM1C NEDD4 FASN CDH20 NDRG1 BRCA1 PER2 BRCA2 AP1M1 AKT2 MMP10 TBXAS1 FLT1 ANK1 SHROOM2 ARAF CUL5 MTOR MACF1 CD74 TP53BP1 | 1.65e-04 | 1074 | 289 | 24 | C0006142 |
| Disease | Miller Dieker syndrome | 1.76e-04 | 29 | 289 | 4 | C0265219 | |
| Disease | Benign tumor of pancreas | 2.47e-04 | 13 | 289 | 3 | C0347284 | |
| Disease | creatine kinase measurement | 2.83e-04 | 59 | 289 | 5 | EFO_0004534 | |
| Disease | Malignant Squamous Cell Neoplasm | 2.85e-04 | 3 | 289 | 2 | C0751688 | |
| Disease | Squamous Cell Neoplasms | 2.85e-04 | 3 | 289 | 2 | C0206720 | |
| Disease | serum gamma-glutamyl transferase measurement | RAPGEF5 NUP210L RYR2 AHNAK HSPA4 ARAP2 ACSS3 KLB SEMA4B ADAM30 USP16 CDC42BPB APIP GPBP1L1 CELF1 PTCD1 PARD3 CABIN1 SLC25A28 ALPK2 TP53BP1 | 2.94e-04 | 914 | 289 | 21 | EFO_0004532 |
| Disease | alpha fetoprotein measurement | 4.62e-04 | 100 | 289 | 6 | EFO_0010583 | |
| Disease | acute lymphoblastic leukemia | 4.78e-04 | 66 | 289 | 5 | EFO_0000220 | |
| Disease | MYELODYSPLASTIC SYNDROME | 5.12e-04 | 67 | 289 | 5 | C3463824 | |
| Disease | Congenital Foot Deformity | 5.66e-04 | 4 | 289 | 2 | C0016508 | |
| Disease | Hereditary breast ovarian cancer syndrome | 5.66e-04 | 4 | 289 | 2 | cv:C0677776 | |
| Disease | brain connectivity measurement | CNNM2 QRICH1 ADGRV1 STK35 NEDD4 WNK2 STON1 NHSL1 PTCD1 LRRC8A SSH2 DAAM1 | 6.39e-04 | 400 | 289 | 12 | EFO_0005210 |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 6.64e-04 | 148 | 289 | 7 | C0279702 | |
| Disease | Chronic myeloproliferative disorder | 8.02e-04 | 19 | 289 | 3 | C1292778 | |
| Disease | Pancreatic carcinoma | 8.02e-04 | 19 | 289 | 3 | C0235974 | |
| Disease | melanoma | 8.09e-04 | 248 | 289 | 9 | C0025202 | |
| Disease | post-operative atrial fibrillation, response to surgery | 9.38e-04 | 5 | 289 | 2 | EFO_0009951, EFO_0009952 | |
| Disease | post-operative stroke, response to surgery | 9.38e-04 | 5 | 289 | 2 | EFO_0009951, EFO_0009956 | |
| Disease | hereditary breast ovarian cancer syndrome (is_implicated_in) | 9.38e-04 | 5 | 289 | 2 | DOID:5683 (is_implicated_in) | |
| Disease | Unipolar Depression | 1.10e-03 | 259 | 289 | 9 | C0041696 | |
| Disease | Seckel syndrome | 1.25e-03 | 22 | 289 | 3 | C0265202 | |
| Disease | colorectal cancer (is_implicated_in) | 1.26e-03 | 121 | 289 | 6 | DOID:9256 (is_implicated_in) | |
| Disease | chronic obstructive pulmonary disease, CC16 measurement | 1.40e-03 | 6 | 289 | 2 | EFO_0000341, EFO_0005080 | |
| Disease | renal overload-type gout | 1.40e-03 | 6 | 289 | 2 | EFO_0021525 | |
| Disease | Adult only | 1.40e-03 | 6 | 289 | 2 | C3842001 | |
| Disease | Neoplasm Metastasis | 1.41e-03 | 217 | 289 | 8 | C0027627 | |
| Disease | airway responsiveness measurement | 1.62e-03 | 24 | 289 | 3 | EFO_0006897 | |
| Disease | Renal Cell Carcinoma | 1.68e-03 | 128 | 289 | 6 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 1.68e-03 | 128 | 289 | 6 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 1.68e-03 | 128 | 289 | 6 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 1.68e-03 | 128 | 289 | 6 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 1.68e-03 | 128 | 289 | 6 | C1306837 | |
| Disease | cortical surface area measurement | USP34 ATXN2L CNNM2 MYCBP2 RAPGEF5 SPTBN1 DAPK1 ADGRV1 CSGALNACT2 VPS35L NR3C2 SEMA6A DIAPH3 WNK2 SEMA4D DNAJC13 IFT22 STON1 NHSL1 RASGEF1C MACF1 PRKD1 SSH2 DAAM1 PARD3 | 1.74e-03 | 1345 | 289 | 25 | EFO_0010736 |
| Disease | breast cancer (implicated_via_orthology) | 1.82e-03 | 25 | 289 | 3 | DOID:1612 (implicated_via_orthology) | |
| Disease | Fanconi Anemia | 1.82e-03 | 25 | 289 | 3 | C0015625 | |
| Disease | Metastatic melanoma | 1.94e-03 | 54 | 289 | 4 | C0278883 | |
| Disease | hippocampus fimbria volume | 1.94e-03 | 7 | 289 | 2 | EFO_0009402 | |
| Disease | CC16 measurement | 1.94e-03 | 7 | 289 | 2 | EFO_0005080 | |
| Disease | Acute lymphocytic leukemia | 1.94e-03 | 7 | 289 | 2 | C0023449 | |
| Disease | bitter alcoholic beverage consumption measurement | 2.04e-03 | 133 | 289 | 6 | EFO_0010092 | |
| Disease | Acute monocytic leukemia | 2.05e-03 | 26 | 289 | 3 | C0023465 | |
| Disease | fibrinogen measurement, factor VII measurement | 2.52e-03 | 58 | 289 | 4 | EFO_0004619, EFO_0004623 | |
| Disease | eosinophil cationic protein measurement | 2.57e-03 | 8 | 289 | 2 | EFO_0010913 | |
| Disease | Chromosomal Instability | 2.57e-03 | 8 | 289 | 2 | C1257806 | |
| Disease | Adenocarcinoma of large intestine | 2.58e-03 | 96 | 289 | 5 | C1319315 | |
| Disease | Major Depressive Disorder | 2.86e-03 | 243 | 289 | 8 | C1269683 | |
| Disease | uric acid measurement | USP34 CNNM2 ADGRV1 ADCY9 HSF5 KLB MOK LRRC8C FAT4 DNAJC13 GRB14 ORC4 SBF2 HERC4 | 2.98e-03 | 610 | 289 | 14 | EFO_0004761 |
| Disease | mean corpuscular hemoglobin concentration | CNNM2 ATR LIN54 NEB ADCY9 PLCB3 DNAJC13 STON1 ANK1 SEPTIN4 HSPA4L GRB14 C16orf96 HNRNPUL1 CYRIB UGT2A3 MACF1 DOT1L SLC25A28 ZNF654 LRIF1 | 3.10e-03 | 1105 | 289 | 21 | EFO_0004528 |
| Disease | age at menopause | 3.11e-03 | 302 | 289 | 9 | EFO_0004704 | |
| Disease | cystic fibrosis (implicated_via_orthology) | 3.29e-03 | 9 | 289 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | Pancreatic carcinoma, familial | 3.29e-03 | 9 | 289 | 2 | C2931038 | |
| Disease | longitudinal alcohol consumption measurement | 3.29e-03 | 9 | 289 | 2 | EFO_0007645 | |
| Disease | temporal lobe epilepsy (biomarker_via_orthology) | 3.41e-03 | 31 | 289 | 3 | DOID:3328 (biomarker_via_orthology) | |
| Disease | Large cell carcinoma of lung | 3.74e-03 | 32 | 289 | 3 | C0345958 | |
| Disease | Mental Retardation, X-Linked 1 | 3.74e-03 | 32 | 289 | 3 | C2931498 | |
| Disease | Fanconi anemia (is_implicated_in) | 4.08e-03 | 10 | 289 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | eosinophil measurement | 4.27e-03 | 108 | 289 | 5 | EFO_0803540 | |
| Disease | Vasodilators used in cardiac diseases use measurement | 4.45e-03 | 34 | 289 | 3 | EFO_0009926 | |
| Disease | schizophrenia (implicated_via_orthology) | 4.49e-03 | 68 | 289 | 4 | DOID:5419 (implicated_via_orthology) | |
| Disease | Glioblastoma Multiforme | 4.80e-03 | 111 | 289 | 5 | C1621958 | |
| Disease | PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER) | 4.96e-03 | 11 | 289 | 2 | C4721541 | |
| Disease | Cognitive impairment | 4.96e-03 | 11 | 289 | 2 | HP_0100543 | |
| Disease | placenta growth factor measurement | 4.96e-03 | 11 | 289 | 2 | EFO_0010626 | |
| Disease | delta-5 desaturase measurement | 4.96e-03 | 11 | 289 | 2 | EFO_0007764 | |
| Disease | pancreatic cancer (is_implicated_in) | 4.98e-03 | 112 | 289 | 5 | DOID:1793 (is_implicated_in) | |
| Disease | myocardial infarction (biomarker_via_orthology) | 5.06e-03 | 160 | 289 | 6 | DOID:5844 (biomarker_via_orthology) | |
| Disease | Adenocarcinoma | 5.77e-03 | 116 | 289 | 5 | C0001418 | |
| Disease | Carcinoma, Granular Cell | 5.77e-03 | 116 | 289 | 5 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 5.77e-03 | 116 | 289 | 5 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 5.77e-03 | 116 | 289 | 5 | C0205642 | |
| Disease | Carcinoma, Cribriform | 5.77e-03 | 116 | 289 | 5 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 5.77e-03 | 116 | 289 | 5 | C0205641 | |
| Disease | interferon alpha measurement | 5.91e-03 | 12 | 289 | 2 | EFO_0006517 | |
| Disease | Mammary Carcinoma, Human | CTU2 FASN NDRG1 BRCA1 BRCA2 AKT2 FLT1 ARAF CUL5 MTOR CD74 TP53BP1 | 5.97e-03 | 525 | 289 | 12 | C4704874 |
| Disease | Mammary Neoplasms, Human | CTU2 FASN NDRG1 BRCA1 BRCA2 AKT2 FLT1 ARAF CUL5 MTOR CD74 TP53BP1 | 5.97e-03 | 525 | 289 | 12 | C1257931 |
| Disease | prostate cancer (is_implicated_in) | 5.98e-03 | 117 | 289 | 5 | DOID:10283 (is_implicated_in) | |
| Disease | lung cancer (is_implicated_in) | 6.06e-03 | 74 | 289 | 4 | DOID:1324 (is_implicated_in) | |
| Disease | Mammary Neoplasms | CTU2 FASN NDRG1 BRCA1 BRCA2 AKT2 FLT1 ARAF CUL5 MTOR CD74 TP53BP1 | 6.14e-03 | 527 | 289 | 12 | C1458155 |
| Disease | non-small cell lung carcinoma | 6.35e-03 | 75 | 289 | 4 | EFO_0003060 | |
| Disease | glycoprotein measurement | 6.42e-03 | 119 | 289 | 5 | EFO_0004555 | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 6.94e-03 | 13 | 289 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | egg allergy measurement, parental genotype effect measurement | 6.94e-03 | 13 | 289 | 2 | EFO_0005939, EFO_0007018 | |
| Disease | Mental Retardation, X-Linked Nonsyndromic | 6.94e-03 | 13 | 289 | 2 | C3501611 | |
| Disease | Charcot-Marie-Tooth disease type 4 | 6.94e-03 | 13 | 289 | 2 | cv:C4082197 | |
| Disease | Skin Abnormalities | 6.94e-03 | 13 | 289 | 2 | C0037268 | |
| Disease | Infantile Refsum Disease (disorder) | 6.94e-03 | 13 | 289 | 2 | C0282527 | |
| Disease | cortical thickness | CNNM2 MYCBP2 INHBA NUP210L RPS6KA2 SPTBN1 ADGRV1 CDH20 DIAPH3 WNK2 SEMA4D IFT22 STON1 GAS7 NHSL1 RASGEF1C LRP1 MACF1 SSH2 PARD3 | 7.05e-03 | 1113 | 289 | 20 | EFO_0004840 |
| Disease | Breast Carcinoma | CTU2 FASN NDRG1 BRCA1 BRCA2 AKT2 FLT1 ARAF CUL5 MTOR CD74 TP53BP1 | 7.18e-03 | 538 | 289 | 12 | C0678222 |
| Disease | Combined immunodeficiency | 7.53e-03 | 41 | 289 | 3 | C0494261 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LTPEVNMHIKEENFF | 61 | P35503 | |
| RVVMPDFKIHASFEN | 371 | A8MVM7 | |
| LKQTMASDPHSLEEF | 331 | Q6ZT62 | |
| GPSDAKEVMEHRFFL | 396 | P31751 | |
| FLHSNKLETLPEEMG | 351 | Q96RT1 | |
| AHFDLKPENIMLLDR | 136 | P53355 | |
| NKVHMGDLDVPLEQE | 256 | Q9NUB1 | |
| HMAKEALENTEVPVG | 31 | Q7Z6V5 | |
| MRAHFGLPSVEKEEV | 356 | Q9Y6Q5 | |
| NVELLKLRFGEAPMH | 541 | Q9UJX6 | |
| GIEPMLKDLEEHIIS | 306 | Q93034 | |
| KTNHSNIMDDPFIRE | 331 | P61201 | |
| LPSDFQERVSLHMEK | 146 | Q9BUH8 | |
| GNVTDFLISHKMEEP | 1616 | Q86TB3 | |
| DHPDQPDLDAIKMFV | 6 | Q92879 | |
| SVILEHFQDLVPKLM | 836 | Q9H7F0 | |
| PMEIFVDDETKLTLH | 246 | Q13838 | |
| LMDPVIFTVAHLEDK | 781 | O94910 | |
| KHRMSFPETVDEILD | 801 | P16157 | |
| AFVEEAQLMAKHPLA | 116 | A6NHR8 | |
| EKFHIDPLRGAIMAA | 2511 | Q6V0I7 | |
| IPEIAESFHIMLLKD | 351 | Q8WXG9 | |
| VNFMDGEEAKPIILH | 1176 | Q8WXG9 | |
| ELLLDPVDFKTTHLM | 341 | Q68CP9 | |
| MRAHFGLPSVEAEDK | 356 | Q9BXS5 | |
| THSPKEVMFLNELEE | 296 | Q13362 | |
| RLDPHFLNNKEMSDV | 911 | A6QL63 | |
| REMGVDVHFPKAEAS | 5676 | Q09666 | |
| ELHMDSPVEKRKNFI | 776 | Q8WZ64 | |
| EARQHLQKMPEGTFL | 91 | Q9NSE2 | |
| DHTPMETVVDIFRKL | 706 | P51793 | |
| QFHKALIELNMDSPE | 341 | Q9H9F9 | |
| GPEVDHQLKERFANM | 246 | Q8TEK3 | |
| NLFHEMETCLKREDP | 1406 | Q9NR16 | |
| PQEFIHELKMGSADE | 176 | Q9NSV4 | |
| KLGIDDLVHFDFMDP | 516 | O43143 | |
| IETQLPALLEAKMHA | 581 | Q9NRI5 | |
| DELPSLMKIQDHFNS | 451 | Q9UHL0 | |
| KPSDVMLVHFRNVDF | 186 | Q8WWM7 | |
| KERAVAQLHGMEDPT | 386 | Q9UF12 | |
| ADEEKEQSHRPFLML | 281 | P08476 | |
| PAERADLKQLMVHAF | 346 | Q02750 | |
| DAHNMLLFETSAKDP | 171 | Q14088 | |
| EMNLSETAFIRKLHP | 41 | P30039 | |
| INDHAPEFPEKEMLL | 126 | Q9Y5E4 | |
| SVPQHRMKEFLDSLA | 21 | Q2TAL8 | |
| LEVHEEPLSGKMEIF | 266 | Q14699 | |
| HLQDSFVDKLLDLMP | 771 | Q96HW7 | |
| LILFDHMVPLVEEIN | 316 | Q96N11 | |
| PDVKNDFAFMLHLID | 366 | Q8IWT6 | |
| DKLELHLFMLSGIPD | 426 | Q8IWT6 | |
| LMDLVEFHEKSPDDQ | 96 | Q16654 | |
| DHAMKIVFLNTDPSI | 241 | Q9H1A4 | |
| EFDPNARMVTHILKS | 456 | P09238 | |
| FEHLQQLELIKPMER | 376 | O43929 | |
| GLTDHQELKMPLFVL | 16 | P0C7N1 | |
| LPFMETELHCDEKTI | 56 | O75884 | |
| EMDFLKNEHFAIPAV | 386 | Q9P260 | |
| VPMIIFAKDGHFALE | 256 | P06132 | |
| PDIMNLLIKSGAHFD | 541 | Q96JP0 | |
| DINDHSPVFLDKQML | 126 | Q9Y5F0 | |
| DIELNGEPVDLHMKL | 66 | Q9BQK8 | |
| FILVRKADMADIPGH | 311 | Q13478 | |
| TPERVFVVMEKLHGD | 651 | Q15139 | |
| NFEESPERKTLMHLA | 631 | Q6MZP7 | |
| FRESHALKVEFPAML | 946 | P08235 | |
| DSVFAHPRKLLMQDL | 236 | P43356 | |
| MRHEELLTKTFQGPA | 1 | Q5XG99 | |
| LEEKPRNVVFVDMGH | 191 | P34932 | |
| FRDQEPKIHNEMAST | 526 | Q5T3J3 | |
| HEEVEGLVEKIRFPM | 336 | Q08380 | |
| FVQDDLEHGLEIMKL | 236 | P46934 | |
| KEVSHEMDGLIFQPT | 431 | O60942 | |
| RSVDDDPRMKHFLNV | 1566 | Q86VF7 | |
| DSMVEVHNKVDLVPG | 411 | O43824 | |
| KGHIDLAEVEMVIPA | 1786 | Q86WG5 | |
| NCLPLTEDELKEFHM | 406 | Q9HC44 | |
| HEALIRTEKGSDPMF | 151 | P60608 | |
| EMLKEEHEVAVLGAP | 21 | Q01628 | |
| MKLDAHGFAPEELVV | 56 | Q9BQS6 | |
| PFEDPEHMKNVIALA | 2226 | Q07954 | |
| DEITMKSEFPLLRQH | 2221 | Q9Y3R5 | |
| HALKMDPDFVDALTE | 131 | Q9BVA6 | |
| AFTVHLKPDENMIAE | 2336 | Q5SZK8 | |
| SHVLTPAEMEAFKQR | 876 | Q14C86 | |
| LDEKPRIVVFVDMGH | 191 | Q92598 | |
| ELIREVEMGPFKHTV | 1061 | Q86VP6 | |
| TPKRIIHFVDGDIME | 21 | A6PVY3 | |
| PKSQELRHFESENIM | 386 | Q5SYE7 | |
| GFKHIPDEDFLNVMT | 71 | Q86YR7 | |
| TDPEFVIDHMDANKA | 81 | P24071 | |
| NVKVLDFEHFLPMLQ | 61 | P60660 | |
| MEESEHFIKCVLQDP | 1121 | O15055 | |
| VFADMDLLHKVVAPA | 1676 | A6NKB5 | |
| KEFSRFHEEITPMLD | 786 | P16499 | |
| LLFEAAVQQDPKHME | 356 | P50542 | |
| ALPDMVVSHLFGKEE | 186 | Q92597 | |
| HEINPRKVFELMGSI | 281 | Q5GLZ8 | |
| TLLHDAAMNPAEVVK | 181 | Q96A46 | |
| TEFHDKIEPMLETLE | 2021 | O94854 | |
| MLNKIFGESEPEIHE | 726 | Q9UBG0 | |
| QEKAMAHADPTELAL | 596 | Q9BSJ2 | |
| PFLMHDFDLKRTTNI | 241 | Q6W3E5 | |
| IPDVKNDFAFMLHLI | 356 | Q6NSJ5 | |
| QDRDFETMAKLHIPV | 61 | P0C7V9 | |
| PNILMLHEVVFDRKS | 61 | Q9UQ07 | |
| IFSGDPEEIRMLIHK | 16 | Q8N8A2 | |
| LEEEMERNKDHPAFA | 81 | P30519 | |
| PFTQLVKEMQLHRED | 61 | Q9Y5S2 | |
| EHSLEGQKFPLEMQI | 141 | P23471 | |
| IIDLPALFKMDEDHR | 566 | Q9Y2J8 | |
| PKIFSIIAEGEMHEA | 1036 | O00410 | |
| QDRDFETMAKLHIPV | 61 | A6NJ78 | |
| FSEMLQSLVVKDPHL | 221 | Q9H579 | |
| HSFIAEKVREIPQAM | 96 | Q9UNW9 | |
| LVQHKGLSEEDIFMP | 146 | Q9NY56 | |
| LHELAQEMEGSDKPQ | 421 | O95672 | |
| AVDFLRGHLVPKEMS | 376 | Q9H6S3 | |
| TQITEFHDKIEPMLE | 5891 | Q9UPN3 | |
| FHDKIEPMLETLENL | 5896 | Q9UPN3 | |
| INDHSPVFLEKEMLL | 126 | Q9Y5F1 | |
| MEFLDKDPEDHRTLS | 96 | Q15119 | |
| PIEHMEDLFALLAAF | 641 | Q8NB91 | |
| MRKNLDPFNEHTDEE | 1131 | O15439 | |
| AEALINPIKHVSLMD | 856 | Q01970 | |
| KMAELEFPQFETLHL | 341 | Q6PIJ6 | |
| MDDLASLKIPEQFRH | 581 | Q9H3D4 | |
| MKELAEEEPHLVEQF | 91 | P40855 | |
| MFPLTEENKHVAQLL | 1 | Q3MIT2 | |
| KNLLEENFEEHSMSP | 996 | P38398 | |
| LTDKHREAMFALPAE | 66 | Q9Y4D1 | |
| MLLKSLGEDVIFHPE | 21 | Q9UKF2 | |
| LEDVPLTMHNFVRKT | 91 | P10398 | |
| EMPELVQHKLDDIFE | 1501 | Q14008 | |
| QREPLMSVLKTFLHD | 2546 | Q13535 | |
| VFQLEMGLTRHPEEK | 156 | Q8N6G5 | |
| HVERKMLQDDSLPAG | 506 | Q8WWV6 | |
| IVFNADIPSHRKEME | 86 | Q9H7X7 | |
| ALHEEFMVPATKALN | 801 | Q6WRI0 | |
| KPVEVISLSRDFMLH | 191 | O75054 | |
| DLPDAQDKFHELMSQ | 281 | A4D1E9 | |
| DFLHLFEKNMIPERT | 301 | A4D1E9 | |
| FEKNMIPERTVEFQH | 306 | A4D1E9 | |
| FPLMEAEVLQRLHDK | 246 | Q53GT1 | |
| MGIDKPDVRFVIHAS | 951 | P54132 | |
| FDRAKHLEFMTSIPE | 721 | Q9Y6J0 | |
| FEIHIEMVKGLAPLQ | 1006 | Q4AC94 | |
| FKPMLAAIADIEHIE | 246 | P49917 | |
| DHIGKSMPNVLEDEV | 281 | P51587 | |
| EDIIKPHMLIAASNL | 3111 | P51587 | |
| VHPERMDIFAEDFKI | 176 | A6NNT2 | |
| LIGEMPQEDLHAVVK | 226 | Q96MS3 | |
| AQMKHIFTEPDEDLF | 356 | Q8TD26 | |
| LKVEGANPHLEMRFL | 351 | Q9HBT6 | |
| REFEPMLQVKGDEDH | 311 | O75417 | |
| HPDLMKILGDINSDF | 406 | P86791 | |
| FLAVPDHVEDMKAGR | 1541 | Q8N1P7 | |
| FKNEGMVLEHPARVE | 271 | Q9Y2G2 | |
| HPDLMKILGDINSDF | 406 | P86790 | |
| QIIFIADDPQEKAMH | 46 | Q5T1N1 | |
| MEQHSQDFIKFLILP | 116 | Q7Z7H3 | |
| PQEHLQILFEFAKEM | 1131 | O60503 | |
| MKDRVNDDLISEFPH | 636 | Q92796 | |
| MIEKIAAHLADFTPR | 1211 | O75165 | |
| KQEMERNEIPFLCHS | 126 | Q9Y6X4 | |
| LPFLILFHMKEDTES | 261 | Q9BS26 | |
| DDAMLIEKFVDTPRH | 241 | Q96RQ3 | |
| ALEQMRKFLSDPQVH | 61 | Q14204 | |
| EGIHPKVMERLIEFA | 126 | Q14145 | |
| VLPIFSEAEKHEMRG | 351 | Q86Z14 | |
| KHFQIIPVEDDGEMF | 486 | Q14449 | |
| NVPFSHLSLEKDNME | 581 | Q9ULL0 | |
| QEHFAEMAASLKRPD | 771 | P20849 | |
| LHFTLRFDELKMTNP | 136 | Q9NUQ9 | |
| LEAFTRDFLPHMKEE | 116 | Q9UKA1 | |
| RDFLPHMKEEEEVFQ | 121 | Q9UKA1 | |
| FEMSRHSLEQKPTDA | 191 | P04233 | |
| AGQMKEIHLESDPVL | 1486 | Q8NDH2 | |
| FTPEQLHLEKELGEM | 36 | B1AMM8 | |
| MNIKHLVDPIDDLFL | 451 | Q7Z3D6 | |
| AMFHTLDKINADPVL | 81 | Q13255 | |
| IIPLMKKDHRDNLEF | 781 | P49327 | |
| DLIREVEMGPFKHTV | 1066 | O75155 | |
| QTEHRLLGPMTFAEK | 316 | Q13183 | |
| RLVFDVPLLNEHAKM | 2591 | Q92736 | |
| EIELMGETPKHFAVQ | 321 | Q8TEX9 | |
| NPKFEVGDIMLIRDH | 121 | P00491 | |
| APEKASIHRLMEAFI | 336 | Q2VPK5 | |
| VGHLSEPLMNRLEDK | 231 | Q969Z0 | |
| KQELHLFMLSGVPDA | 471 | Q7L1W4 | |
| LNKMELLPFHADVEI | 546 | Q5VU65 | |
| MESVADHEPNKRILG | 1156 | Q5THK1 | |
| PVFFENEMHLKILES | 131 | Q9Y5E6 | |
| EHIPNFSLDDMVKLV | 261 | Q8TEW0 | |
| HAVLEMKANFTLPDV | 556 | Q9BUJ2 | |
| DINDHSPVFLDKQML | 126 | Q9UN66 | |
| PEDFLEMDLAKNEHR | 501 | O15403 | |
| KEDFHNLMAVSPSLV | 261 | Q9UPX6 | |
| ERNVKGMFEVLEPLH | 2041 | P42345 | |
| LLFPGREFKITHQEM | 126 | Q96GX9 | |
| LGFLHNMPKEEEEEE | 681 | Q96P20 | |
| GLTDHQELKMPLFVL | 16 | Q8NH10 | |
| IRDPFIHEISKIAMG | 1166 | Q5JY77 | |
| QELPGKVHRFEAMDS | 441 | Q9H611 | |
| KVHRFEAMDSNPELA | 446 | Q9H611 | |
| SMPLIGDHQDEDKQL | 391 | P17600 | |
| FQIVDELHSSPKLEM | 376 | Q4G112 | |
| SPDSELHRVFQKEMA | 391 | A4D263 | |
| QKEMAVDLFRHQAPL | 401 | A4D263 | |
| AFPHTDLAKLDDMIN | 66 | Q93008 | |
| IAMLFEEAFVHLKPQ | 421 | Q9NYH9 | |
| DHPKMTELFQSLADL | 2841 | P46939 | |
| DGLEQMHKDLVNVPL | 2916 | P46939 | |
| VEISHPDGKVENLFM | 326 | Q8TEU7 | |
| LDFMDSLEHDIPKGS | 211 | Q9H1X1 | |
| KPNLEKHEEMFQGLR | 961 | B4DYI2 | |
| GLRPLDVEFMKALHQ | 266 | O43236 | |
| LVADFMKLEEPHVAT | 611 | Q8N3T6 | |
| RHKQVPFEEQEGMSH | 946 | Q14C87 | |
| EEMQPLHEDNFSREK | 1056 | Q5JRA6 | |
| HGDIPNMEDVLAVKS | 411 | Q8N0V4 | |
| LHPDEVIVKNQLDMF | 536 | Q969Y0 | |
| KAREGVMEFLLANHP | 111 | P28331 | |
| FGICPHMTEDNKDLI | 241 | P30101 | |
| FLLLMDKIRDPFIHE | 601 | Q96D09 | |
| LHSEVEKPLMNFREN | 296 | O60861 | |
| PHFDQLVAAFDKMIR | 906 | O15197 | |
| FHQQFLLPELEKRME | 431 | P98174 | |
| PDRVLNFLKDHFLMD | 416 | Q9NPR2 | |
| FMPLLLKDVTFIHEG | 496 | Q92565 | |
| EVLQKEMLPHVGVSD | 341 | P30876 | |
| LMEGIFPKDEHLLEE | 1346 | Q13796 | |
| KVEHPVEMGLDLEQS | 66 | Q7Z7L1 | |
| KGLTMLDHEQVTPED | 61 | Q9UBE0 | |
| HDDFQRMTSIPKEEL | 4621 | O75592 | |
| ELKDHPITQFSLLAM | 306 | Q8N3P4 | |
| IRPFFLKHESQMDSV | 141 | Q00765 | |
| LQFVKDHPLMDDSVT | 391 | Q92854 | |
| FSPVMDHSREKDNDL | 1086 | Q9P2P6 | |
| MDDFKFSAELIQHIP | 551 | Q8IYB8 | |
| RKPNLEKHEEMFQGL | 966 | P0DKV0 | |
| EKHEEMFQGLRTPQL | 971 | P0DKV0 | |
| FAQMLPRDQHLFTKE | 606 | Q9UQ90 | |
| HMPVLRQKEESFQFI | 1056 | Q7Z745 | |
| NIFEPHVAVRDAAKM | 201 | Q9Y399 | |
| EETFRKLQLSGHAMP | 151 | Q13586 | |
| MDELDVRLPFHAENF | 916 | Q96J65 | |
| IFDPVTREDLHMDFK | 311 | P27930 | |
| FLQPVHKIDMNLTDL | 231 | Q15437 | |
| PNIVHMLDSFETDKE | 61 | Q9NRP7 | |
| PEVLDDSINMKHFES | 381 | P36897 | |
| PHKDQRQMFFVISLD | 246 | Q08945 | |
| KFMELLEPLNERKHN | 1466 | Q01082 | |
| ERHESMPDVLKIAQF | 516 | Q9UK61 | |
| MGTVFEKPLLDHLNA | 406 | Q8N4F0 | |
| QVDMKLLEGHVPEEA | 3866 | Q8IVF2 | |
| EALGFPMLEKEEEAH | 651 | P35611 | |
| EDPSIFGHVEEMLKQ | 671 | Q9H6R3 | |
| REIFSTPGMKHENLL | 231 | Q13705 | |
| PLHFVFNDTKLDAML | 521 | Q9H8M5 | |
| FADLPCELQDMVRKH | 191 | Q5JTD0 | |
| RIHTKAEGFMDVDIP | 36 | Q9Y3V2 | |
| EKHMAPEFCSLEEGL | 376 | P24557 | |
| VGEALLENPKMELHI | 476 | Q8TDR2 | |
| PRELKAFLEHMSEVQ | 601 | Q9H270 | |
| KGFDPLLVEEALEMH | 436 | Q9NZ09 | |
| LADVIKHMTPDRAFE | 526 | Q7Z3J2 | |
| VLHGDIPQDFEMESK | 776 | Q9Y5T5 | |
| VGNKRIEFHISTDMP | 316 | Q96LT9 | |
| ENFMSLQEIPKTPDH | 401 | Q9BUI4 | |
| LFVGHNMLLVSEEPK | 146 | Q7Z7H8 | |
| VVHEPDIEQMLKLGS | 366 | Q9Y6Q2 | |
| HVPEMANKFPDLTVE | 581 | Q76I76 | |
| LDEKPRNVVFIDMGH | 191 | O95757 | |
| HPVKREINEEMKNFA | 21 | A7XYQ1 | |
| RTAKFFILEHQMDPT | 321 | Q8N431 | |
| LLTKEEMRTFHFPLQ | 191 | Q96IC2 | |
| DDTLNFIKTHPLMDE | 386 | Q9H2E6 | |
| HEEIMDAKPELLAFQ | 446 | Q9Y4K3 | |
| PQLHLSSESKEEMFL | 1606 | Q6ZS81 | |
| MSPVEDQLFREHLLK | 241 | Q8IZM8 | |
| PFHTAREMANAKEIA | 41 | P13686 | |
| PHQSELELKFDMALR | 171 | C9JH25 | |
| VRFPAEMQKHVGTLD | 341 | Q96LQ0 | |
| GEELKEENMESVPLH | 676 | Q12888 | |
| PQTDFLHKGMLELEA | 71 | A6NFE2 | |
| EINNHSKPMEIDGDV | 151 | Q9BQ87 | |
| TKEMQADDELLHPLG | 306 | Q9BVS4 | |
| DMLHFKLELPLQSTE | 116 | Q9H6L2 | |
| TLPDDLHFLNLEGMK | 1031 | Q86YA3 | |
| DELHRLCKDVFPAQM | 31 | Q969M1 | |
| ALKFEVVHMPQDRTE | 71 | Q6UWM9 | |
| DEDVPDFLMHKLTAS | 151 | Q8NET8 | |
| ELETFMLKHGENIID | 526 | Q6PML9 | |
| ENPEHNDFLKLRTML | 266 | Q15019 | |
| EKVNTHFSFPLRLDM | 2101 | Q70CQ2 | |
| EEAEMLKGLQHPNIV | 241 | Q9Y3S1 | |
| EDLEFQAKHMDQPLP | 621 | Q01831 | |
| LEGFLSKMAEHRQQP | 471 | O75127 | |
| DLFFLNKDAALHMEP | 926 | P17948 | |
| HVNTRLDVKMFEDPV | 461 | P31629 | |
| LHQAGEKLSPEEEML | 1496 | Q6ZQQ6 | |
| VNMEEFKSHSPERSI | 126 | Q8TAF7 | |
| FDEMDKLHPGIIDAI | 176 | O14657 | |
| AARSVFLHLMKVDPD | 1026 | O43156 | |
| KMHEAIFDLLPEEQT | 896 | Q9P1Q0 | |
| EEHPGSRMTAEKFLN | 321 | Q5T124 | |
| QKSFALPEMSLDDHP | 1751 | Q9P2D8 | |
| SKMERDILAEVNHPF | 106 | Q15349 | |
| DDIPDVKNDFAFMLH | 361 | Q8TDW0 | |
| KIEEMDPSFNLHETI | 616 | Q58DX5 | |
| RKDSPQLLMDAKHIF | 1811 | Q9Y4I1 | |
| FDQIMKSDPDHLAEL | 766 | Q9UM54 | |
| LGADRPMSNLEKVHF | 1081 | Q6PIF6 | |
| EKMRLHGELDVNFNP | 486 | Q8NFW9 | |
| SLEDDPKLVHFMQVA | 1836 | P20929 | |
| HTMEFALVKALEPEE | 161 | Q99608 |